DRUGS related term(s) Crime; Pharmaceuticals

Addresses

State of the Union: President Biden, S891–S896 [1MR], H1200–H1206 [1MR]

Affidavits

Affadavit of William Julié, E1082 [25OC]

Amendments

Dept. of HHS: establish Advanced Research Projects Agency-Health (H.R. 5585), H5802 [22JN]

——— establish Advanced Research Projects Agency-Health (H.R. 5585), consideration (H. Res. 1191), H5750 [22JN]

——— reauthorize certain programs relative to mental health and substance use disorders (H.R. 7666), H5783, H5784, H5785, H5786, H5788, H5789, H5790, H5791, H5792, H5793 [22JN]

——— reauthorize certain programs relative to mental health and substance use disorders (H.R. 7666), consideration (H. Res. 1191), H5750 [22JN]

——— support behavioral needs of students and youth, invest in school-based behavioral workforce, and ensure access to mental health and substance use disorder benefits (H.R. 7780), H8238, H8249, H8250 [29SE]

Diseases and disorders: making supplemental appropriations for coronavirus emergency response and relief (H.R. 7007), consideration (H. Res. 973), H1393 [9MR]

Economy: use of budget reconciliation to fight inflation, reduce prescription drug and health care costs, address climate change, increase tax fairness, and reduce deficit (H.R. 5376), S3922 [3AU], S4070, S4145, S4170, S4171, S4172, S4178, S4179, S4180, S4181, S4184, S4185, S4186, S4187, S4190, S4191, S4192, S4197, S4199, S4200, S4221, S4222, S4225, S4226, S4231, S4234, S4237, S4238, S4243, S4244, S4245, S4247, S4248, S4249, S4250, S4252, S4253, S4256, S4257, S4292, S4295, S4296, S4297, S4298, S4301, S4306, S4310, S4311, S4312, S4313, S4316, S4317, S4320, S4321, S4322, S4323, S4324, S4325, S4326, S4327, S4329, S4331, S4334, S4335, S4336, S4337, S4338, S4339, S4341, S4342, S4343, S4344, S4345, S4346, S4347, S4348, S4349, S4350, S4360, S4361, S4376, S4397, S4399 [6AU], H7577 [12AU]

Insurance: establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), S5094 [27SE], S5148, S5247, S5254, S5312, S5335, S5398, S5506 [28SE], S5518 [29SE], H8331 [30SE]

——— establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), consideration (H. Res. 1017), H4031 [31MR]

——— establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), consideration of Senate amendment (H. Res. 1404), H8329 [30SE]

Marijuana: decriminalize, expunge prior convictions, tax products to create programs for those adversely affected by War on Drugs, and provide assistance and collect data on small businesses (H.R. 3617), H4106, H4107, H4108 [1AP]

——— decriminalize, expunge prior convictions, tax products to create programs for those adversely affected by War on Drugs, and provide assistance and collect data on small businesses (H.R. 3617), consideration (H. Res. 1017), H4031 [31MR]

——— streamline, coordinate and expand research and foster increased communication between doctors and patients relative to cannabidiol and other marijuana components and their medical benefits (S. 253), S1781 [24MR]

Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: extend (S. 1216), S955 [2MR]

Analyses

Americans Don’t Support Surrendering Innovation for Democrats’ Drug Price Controls: Committee on Ways and Means (House) Republican staff, H7675 [12AU]

Inflation Reduction Act Budgetary and Macroeconomic Effects: University of Pennsylvania Wharton School, H7670 [12AU]

Articles and editorials

After Roe, Urgent Questions About Cancer Care, S3622–S3624 [25JY]

Americans Give Health Care System Failing Mark—AP-NORC Poll, S4554 [13SE]

Are You High? The Science of Testing for Marijuana Impairment Is Hazy, and Evolving. Lawmakers, Police, Prosecutors Grapple With How To Define Marijuana Impairment, H4101 [1AP]

Cannabis Liberalization in the US—The Policy Landscape, H4103–H4105 [1AP]

5 Gimmicks in Democrats’ Reconciliation Bill, H7675 [12AU]

For Older Americans, Health Bill Will Bring Savings and ‘Peace of Mind’, H7567 [12AU]

Insulin Copay Cap Passes House Hurdle, But Senate Looks for a Broader Bill, H7676 [12AU]

Is Marijuana Addictive?, H4099 [1AP]

Legalized Marijuana Linked to a Sharp Rise in Car Crashes, H4100 [1AP]

Myths About Fentanyl Persist as Opioid Continues To Cause Overdose Deaths, H8749 [5DE]

Opioid Epidemic Is Surging Among Black People Because of Unequal Access to Treatment, H8747–H8749 [5DE]

Over 230 Economists Warn Manchin’s Spending Bill Will Perpetuate Inflation, H7650 [12AU]

‘‘Talk About Clusterf---’’—Why Legal Weed Didn’t Kill Oregon’s Black Market, H4088–H4090 [1AP]

U.S. Grapples With How To Gauge Just How High Cannabis Users Are, H4102 [1AP]

Bills and resolutions

Abortion: preempt State restrictions on dispensing mifepristone or misoprostol (see H.R. 8976), H8112 [22SE]

Agriculture: promote production of hemp and hemp products (see H.R. 6645), H1074 [8FE]

American Rescue Plan Act: rescind certain amounts appropriated to reduce national debt (see H.R. 7699), H4796 [10MY]

Animals: recognize contributions of service animals and their human handlers for bravery in both war and peace and support creation of process to nominate animals for Medal of Bravery and Distinguished Service Medal (see H. Res. 935), H1132 [18FE]

Armed Forces: establish certain protections for members who refuse to receive vaccinations against coronavirus (see H.R. 7570), H4458 [25AP]

——— establish certain protections for members who refuse to receive vaccinations against coronavirus and increase basic pay for members of uniformed services (see H.R. 6429), H252 [19JA]

——— modify treatment of certain controlled substance violations under Uniform Code of Military Justice (see H.R. 7446), H4431 [7AP]

——— preserve readiness by limiting separations based on coronavirus vaccination status and continuing pay and benefits for members while religious and health accommodations are pending (see S. 4925), S4969 [22SE]

——— prohibit adverse action toward members who refuse to receive coronavirus vaccine (see H.R. 6649), H1074 [8FE]

——— reinstate servicemembers involuntarily separated solely due to refusal to receive vaccination against coronavirus (see H.R. 6633), H1013 [7FE]

Aviation: require interagency strategy for creating unified posture on counter-unmanned aircraft systems (C–UAS) capabilities and protections at U.S. international borders (see S. 4919), S4969 [22SE]

Bureau of Prisons: improve treatment of Federal prisoners who are primary caretaker parents (see S. 5206), S7034 [7DE] (see H.R. 9494), H9688 [12DE]

Children and youth: prohibit manufacturing or distributing candy-flavored controlled substances for minors (see H.R. 8839), H7880 [15SE]

Commission on the Federal Regulation of Cannabis: establish (see S. 5166), S6941 [1DE] (see H.R. 7513), H4442 [14AP]

Committee on Foreign Investment in the U.S.: increase oversight of foreign direct investment in U.S. agricultural land (see S. 4821), S4541 [12SE]

Contraceptives: preempt State bans on prescription, provision, or use of drug, biological product, or device for contraception if approved, licensed, cleared, or otherwise authorized for human use by FDA for contraception (see H.R. 8421), H6882 [19JY]

Controlled Substances Act: amend to fix technical error in definitions (see S. 4235), S2544 [17MY] (see H.R. 9178), H8395 [14OC]

Courts: establish appropriate penalties for cocaine-related offenses (see S. 4116), S2219 [28AP]

——— permit civil actions against U.S. or any State or local government entity for coronavirus vaccination mandates (see H.R. 6811), H1139 [22FE]

——— strip foreign sovereign immunity of certain foreign states to secure justice for victims of fentanyl overdoses in U.S. (see H.R. 8194), H5823 [22JN]

Crime: combat fentanyl crisis (see S. 4782), S4045 [4AU]

——— create expungement mechanism and process to petition for expungement for low-level marijuana crimes and study impact of expungements issued (see H.R. 8557), H7403 [28JY]

——— direct President to provide documents to House of Representatives relative to communications with several agencies on recommendations to reduce availability of illicitly manufactured fentanyl-related substances (see H. Res. 1274), H7170 [26JY]

——— enhance penalties for use of spotters or destruction of fences, cameras, or other devices to intentionally hinder immigration, border, and customs controls (see S. 4570), S3542 [20JY]

——— express that transnational criminal organizations, including illicit economies, illicit trade, and trade-based money laundering, threaten national interests and national security of U.S. and its allies (see S. Res. 610), S2275 [3MY] (see S. Res. 874), S7311 [19DE]

——— modify statutory definitions relating to narcotics and drug trafficking (see S. 5234), S7101 [12DE]

——— prohibit certain acts related to fentanyl, analogues of fentanyl, and counterfeit substances (see S. 4151), S2358 [5MY] (see H.R. 8175), H5822 [22JN]

——— prohibit certain dangerous drone aircraft activity (see S. 3542), S442 [1FE] (see H.R. 7965), H5332 [7JN]

——— prohibit Federal funding for any State, local, Tribal, or private entity that operates or controls injection center in violation of Controlled Substances Act (see H.R. 7029), H1422 [9MR]

——— prohibit Federal funding to operate or control injection center in violation of Controlled Substances Act (see H.R. 6741), H1123 [15FE]

——— prohibit health care providers from administering coronavirus vaccines to minors without parental consent (see H.R. 6676), H1112 [9FE]

——— provide for punishment for knowing distribution of fentanyl if death results (see H.R. 8228), H5918 [24JN]

——— punish distribution of fentanyl resulting in death as felony murder (see S. 4876), S4639 [15SE] (see H.R. 8845), H7880 [15SE]

——— seal records for Federal nonviolent criminal offenses related to substance use disorders (see S. 5146), S6857 [29NO]

——— treat illicit fentanyl as weapon of mass destruction (see H. Res. 1172), H5486 [13JN]

——— urge development of strategy to counter rise in violent crime (see S. Res. 636), S2519 [16MY] (see H. Res. 1227), H6623 [14JY]

DEA: codify temporary scheduling order for fentanyl-related substances by adding fentanyl-related substances to schedule I of Controlled Substances Act (see S. 3457), S118 [10JA]

——— include fentanyl-related substances under schedule I of Controlled Substances Act, designating they have high potential for abuse and no medical use (see H.R. 6946), H1328 [7MR]

——— make permanent scheduling of fentanyl-related substances (see H.R. 6713), H1119 [11FE]

——— modify registration requirements relative to research with controlled substances (see S. 5123), S6779 [17NO]

——— provide for life imprisonment for certain offenses involving fentanyl (see H.R. 6439), H288 [20JA]

——— require removal of drug from scheduling within certain period pursuant to recommendation of Dept. of HHS (see H.R. 8931), H8064 [21SE]

Death and dying: ensure individuals facing end of their lives have access to quality medical, palliative, and hospice care and oppose Federal policies or practices that support or facilitate assisted suicide (see H. Con. Res. 68), H976 [4FE]

Dept. of Defense: implement Inspector General recommendations relative to mitigation of foreign suppliers in pharmaceutical supply chain (see H.R. 6374), H77 [12JA]

——— modify limitation on discharge of Armed Forces members solely on basis of failure to obey lawful order to receive coronairus vaccine (see S. 4172), S2419 [10MY] (see H.R. 7936), H5232 [3JN]

Dept. of Education: develop and disseminate evidence-based curriculum for kindergarten through grade 12 on substance use disorders (see S. 5105), S6740 [16NO]

——— prohibit Federal funding to local educational agency requiring any student at schools served by agency to wear face covering or be vaccinated against coronavirus (see H.R. 6456), H288 [20JA]

——— provide grants for institutions of higher education to prevent alcohol and substance misuse (see H.R. 6493), H301 [25JA]

——— study student mental health at institutions of higher education and issue guidance on compliance with Americans With Disabilities Act for mental health and substance use disorder policies (see H.R. 7370), H4126 [1AP]

Dept. of HHS: allow grantees under HIV Health Care Services Program to allocate portion of such funding for services to individuals at risk of acquiring HIV (see S. 4395), S2940 [14JN]

——— allow women greater access to safe and effective oral contraceptive drugs intended for routine use (see S. 4638), S3743 [27JY] (see H.R. 8428), H6882 [19JY]

——— amend Health Resources and Services Administration Counter Measure Injury Compensation Program relative to coronavirus vaccines (see S. 3810), S1119 [10MR]

——— amend Public Health Service Act relative to determinations regarding certain biosimilar application elements (see H.R. 7047), H1423 [9MR]

——— award grants, contracts, or cooperative agreements to facilitate funding of community-based mental health and substance use disorder services and peer support programs (see S. 3688), S785 [17FE]

——— award grants, contracts, or cooperative agreements to schools and school-based health centers to increase number of mental health and substance use disorder care providers (see H.R. 7672), H4721 [6MY]

——— clarify conditions to approve generic drug applications with labeling temporarily different than brand name drug (see S. 4351), S2785 [6JN] (see H.R. 6973), H1372 [8MR]

——— collect and disseminate information on pharmaceutical affordability assistance programs to consumers and health facilities (see S. 4481), S3159 [23JN]

——— conduct demonstration program to test providing preferential treatment under Medicare, Medicaid, and Children’s Health Insurance Program for certain drugs and biologicals manufactured in U.S. (see S. 3991), S1980 [5AP] (see H.R. 7400), H4190 [5AP]

——— conduct outreach campaign to inform individuals covered under group health plan or individual health insurance coverage of Federal requirements relative to mental health and substance use disorder crisis services (see H.R. 8892), H7965 [19SE]

——— conduct study on unintended impacts of sex trafficking legislation and loss of online services and platforms on health and safety of sex workers (see S. 3758), S991 [3MR] (see H.R. 6928), H1302 [3MR]

——— contract with third-party organizations to carry out independent value assessments for approved drugs (see H.R. 9321), H8541 [16NO]

——— disapprove rule entitled ‘‘Vaccine and Mask Requirements To Mitigate the Spread of COVID–19 in Head Start Programs’’ (see S.J. Res. 39), S674 [14FE] (see H.J. Res. 81), H4453 [21AP]

——— enhance efforts to address antibiotic resistance (see H.R. 9094), H8370 [30SE]

——— ensure certain Native American facilities receive items from strategic national stockpile and qualified pandemic or epidemic products (see S. 3444), S49 [5JA] (see H.R. 6372), H43 [11JA]

——— establish Advanced Research Projects Agency-Health (H.R. 5585), consideration (see H. Res. 1191), H5733 [21JN]

——— establish automated supply-chain tracking application that provides near real-time insight into amount of critical medical and health supplies available in strategic national stockpile (see H.R. 6520), H307 [28JA]

——— establish fentanyl lethality awareness campaign, establish Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and provide grants to mitigate effects of drug misuse (see S. 4358), S2865 [8JN] (see H.R. 9221), H8409 [21OC]

——— establish grant programs to help health care providers expand mental, emotional, behavioral, and substance use disorder health services for chidren and youth (see S. 4472), S3159 [23JN]

——— establish program to reimburse health care providers for furnishing rabies postexposure prophylaxis to uninsured individuals (see H.R. 8995), H8220 [28SE]

——— evaluate process by which interchangeable biological products are approved to be used in pharmaceuticals (see H.R. 8877), H7964 [19SE]

——— expand opioid overdose reversal medication access, education, and co-prescribing grant programs (see S. 4794), S4479 [7SE]

——— grant eligible researchers access to drugs or biologic products at discounted price for qualified research (see S. 4026), S2091 (see S. 4053), S2092 [7AP] (see H.R. 7472), H4432 [7AP]

——— improve inspections of foreign drug manufacturing establishments (see H.R. 7006), H1421 [9MR]

——— improve operation of Organ Procurement and Transplantation Network (see S. 5314), S9625 [20DE]

——— increase unannounced inspections of foreign human drug establishments and evaluate differences between domestic and foreign establishments, including impact of advanced notice to establishment owners (see H.R. 6980), H1373 [8MR]

——— issue guidance on strategies under Medicaid and Children’s Health Insurance Program to increase mental health and substance use disorder care provider education, training, recruitment, and retention (see S. 5043), S5542 [29SE]

——— maintain list of country of origin of all drugs marketed in U.S. and ban use of Federal funds for purchase of drugs manufactured in China (see H.R. 7121), H3826 [17MR]

——— make certain improvements to block grants for substance use prevention, treatment, and recovery services (see H.R. 7235), H3894 [28MR]

——— open public docket for submission of public comments on factors that should be considered when reviewing proposed modification to approved risk evaluation and mitigation strategy (see H.R. 7649), H4713 [3MY]

——— prevent and address misuse of opioids and other drugs commonly used in pain management or injury recovery by students and student athletes (see S. 3940), S1803 [28MR] (see H.R. 7246), H3895 [28MR]

——— prohibit discrimination and preferential treatment on basis of race, color, or national origin in administration of health programs (see H.R. 6463), H288 [20JA]

——— prohibit from placing any coronavirus vaccine on child and adolescent immunization schedule without posting all clinical data on safety and efficacy of such vaccine (see S. 5171), S6941 [1DE] (see H.R. 9404), H8729 [2DE]

——— prohibit from restricting access to coronavirus monoclonal antibody therapies based on race or ethnicity (see H.R. 6625), H1012 [7FE]

——— prohibit hospitals from removing individuals from organ transplant lists based on coronavirus vaccination status (see H.R. 7225), H3863 [24MR]

——— prohibit Organ Procurement and Transplantation Network from requesting coronavirus vaccination status of individuals for national list of individuals who need organs (see H.R. 6540), H329 [1FE]

——— prohibit use of Federal funds to purchase, or support purchase of, drug paraphernalia (see H.R. 6704), H1118 [11FE]

——— prohibit use of Federal funds to purchase sterile needles or syringes for injection of illegal drugs, or for pipes, or other paraphernalia that can be used to smoke, inhale, or ingest narcotics (see S. 3645), S674 [14FE] (see H.R. 6744), H1123 [15FE]

——— provide for appropriate cost-sharing for insulin products covered under Medicare part D and private health plans (see S. 3700), S786 [17FE]

——— provide for designation of institutions of higher education as Centers of Excellence in Cannabis Research (see H.R. 8540), H7255 [27JY]

——— provide for suspension of entries and imports from designated countries to prevent spread of communicable diseases and import of certain controlled substances (see H.R. 7586), H4510 [26AP]

——— provide grants to medical and other health professional schools to expand or develop education and training programs for substance use prevention and treatment (see H.R. 9007), H8220 [28SE]

——— provide grants to States, local governments, and Indian Tribes to establish, expand, or maintain Drug Overdose Fatality Review Teams (see S. 4091), S2189 [27AP]

——— reauthorize and expand grant program for State and Tribal response to opioid and stimulant use and misuse (see S. 4839), S4575 [13SE]

——— reauthorize and improve block grants for prevention and treatment of substance abuse (see S. 4301), S2708 [25MY]

——— reauthorize certain mental health programs (see S. 4170), S2419 [10MY]

——— reauthorize certain programs relative to mental health and substance use disorders (see H.R. 7666), H4721 [6MY]

——— reauthorize certain programs relative to mental health and substance use disorders (H.R. 7666), consideration (see H. Res. 1191), H5733 [21JN]

——— reauthorize certain programs relative to mental health conditions and substance use disorders (see H.R. 7234), H3894 [28MR]

——— reauthorize certain programs to reduce opioid overdose deaths (see H.R. 7681), H4721 [6MY]

——— reauthorize grant program for screening, assessment, and treatment services for maternal mental health and substance use disorders (see S. 3824), S1153 [14MR] (see H.R. 7073), H3742 [15MR]

——— request President and direct Sec. of HHS to transmit documents to House of Representatives relative to any coronavirus vaccine (see H. Res. 1244), H7066 [21JY]

——— request President and direct Sec. of HHS to transmit documents to House of Representatives relative to ivermectin (see H. Res. 1355), H7882 [15SE]

——— require drug manufacturers to include printed inserts containing drug information when they ship their products to pharmacies (see H.R. 6519), H307 [28JA]

——— require Inspector General investigation and report on Vaccine Adverse Event Reporting System (see H.R. 7308), H4071 [31MR]

——— revise opioid treatment program admission criteria to eliminate requirement that patients have been addicted for at least 1 year prior to being admitted for treatment (see H.R. 7238), H3894 [28MR]

——— support behavioral needs of students and youth, invest in school-based behavioral workforce, and ensure access to mental health and substance use disorder benefits (see H.R. 7780), H5009 [16MY]

——— support endemic fungal disease research, incentivize valley fever vaccine development, and discover new antifungal therapies and diagnostics to fight infections such as Valley Fever (see S. 3498), S220 [13JA]

——— update National Action Plan for Adverse Drug Event Prevention to provide information on adverse drug events and pharmacogenomic testing and improve electronic health records for pharmacogenomic information (see H.R. 6875), H1176 [28FE]

Dept. of Homeland Security: authorize to perform certain drug enforcement functions (see H.R. 9093), H8370 [30SE]

——— designate illicit fentanyl as weapon of mass destruction (see H.R. 9162), H8385 [7OC]

——— develop comprehensive plan to identify, deploy, and integrate emerging technologies to achieve greater situational awareness along northern and southern borders of U.S. (see H.R. 6794), H1131 [18FE]

——— direct Sec. of Homeland Security to transmit documents to House of Representatives relative to impact of illegal immigration on Federal or Tribal lands (see H. Res. 1250), H7072 [22JY]

——— establish integrated border intelligence analytical cell and Joint Task Force to combat transnational organizations exploiting migration surges and strengthen cross-border partnerships (see H.R. 7756), H4920 [12MY]

——— improve collection of intelligence relative to activities by drug trafficking organizations in certain foreign countries (see H.R. 8561), H7404 [28JY]

——— prohibit from requiring coronavirus vaccination for essential critical infrastructure workers crossing border (see S. 3694), S785 [17FE]

——— provide for operations of U.S. Customs and Border Protection in foreign countries (see H.R. 9167), H8390 [11OC]

——— provide training to personnel on use of containment devices to prevent exposure to potential synthetic opioids (see S. 5114), S6740 [16NO]

——— require comprehensive southern border strategy (see S. 4642), S3743 [27JY] (see H.R. 7260), H3970 [29MR]

——— require Countering Weapons of Mass Destruction Office to treat illicit fentanyl as weapon of mass destruction (see H.R. 8030), H5485 [13JN]

——— require reports, evaluations, and research on drug interdiction technologies to deter fentanyl shipments along border (see S. 5052), S5542 [29SE] (see H.R. 8316), H5940 [7JY]

——— restrict flow of illicit drugs into U.S. (see S. 4645), S3743 [27JY] (see H.R. 9050), H8314 [29SE]

——— secure southern border, provide earned path to citizenship, make e-verify mandatory, and establish American Worker Fund using immigrant restitution payments (see H.R. 6637), H1073 [8FE]

Dept. of HUD: authorize grant program to assist State and local governments, Continuums of Care, and community-based organizations that administer health and homelessness services to better coordinate those services (see S. 4482), S3159 [23JN] (see H.R. 7716), H4860 [11MY]

——— provide funding to affordable housing owners for resident supportive services (see H.R. 6602), H975 [4FE]

Dept. of Justice: clarify eligibility for public safety officer death and disability benefits for officers exposed to radiation at clandestine drug laboratories (see H.R. 8458), H7065 [21JY]

——— provide for Comprehensive Opioid, Stimulant, and Substance Abuse Program pilot program for local law enforcement agencies in rural areas to purchase naloxone to prevent and reduce opioid overdose deaths (see H.R. 6593), H947 [3FE]

——— reauthorize Justice and Mental Health Collaboration Program (see S. 3846), S1225 [16MR] (see H.R. 8166), H5733 [21JN]

——— register practitioners to transport controlled substances to States in which practitioner is not registered to administer substances at places outside of principal places of business (see H.R. 7259), H3895 [28MR]

——— reprioritize Federal law enforcement funds from prosecuting nonviolent pro-life demonstrators to prosecuting violent offenders and drug traffickers (see S. 5084), S6668 [14NO]

——— require electronic communication service providers and remote computing services to report unlawful sale and distribution of controlled substances (see S. 4858), S4638 [15SE]

——— require electronic communication service providers and remote computing services to report unlawful sale and distribution of counterfeit substances and certain controlled substances (see S. 5297), S7311 [19DE]

Dept. of Labor: expand definition of supportive services to include mental health treatment, substance use disorder treatment, and Internet access (see H.R. 7406), H4191 [5AP]

——— provide for enforcement of mental health and substance abuse disorder parity requirements (see H.R. 7767), H4970 [13MY]

——— require action plan within Workforce Innovation and Opportunity Act one-stop delivery system to meet needs of individuals who have experienced trauma, mental health challenges, or substance use disorder (see H.R. 7921), H5227 [31MY]

Dept. of State: designate international criminal gang MS–13 as foreign terrorist organization (see H.R. 7024), H1422 [9MR]

——— require reporting of certain improvements in International Narcotics Control Strategy Report (see H.R. 8798), H7741 [9SE]

——— submit report on designation of Reynosa/Los Metros faction of Gulf Cartel, Jalisco New Generation Cartel, Sinaloa Cartel, and Cartel Del Noreste faction of Los Zetas as foreign terrorist organizations (see S. 4914), S4913 [21SE]

Dept. of the Interior: direct Sec. of the Interior to transmit documents to House of Representatives relative to impact of illegal immigration on Federal or Tribal lands (see H. Res. 1249), H7072 [22JY]

Dept. of the Treasury: make updates to National Strategy for Combating Terrorist and Other Illicit Financing (see H.R. 6388), H78 [12JA]

Dept. of Veterans Affairs: authorize health care providers to provide recommendations and opinions to veterans regarding participation in State marijuana programs (see H.R. 8197), H5877 [23JN]

——— expand access to Veterans Community Care Program to include certain veterans seeking mental health or substance-use services and toxic-exposed veterans (see S. 5348), S9779 [21DE]

——— make certain improvements in mental health care (see H.R. 6411), H216 [18JA]

——— provide for policy on medicinal cannabis (see H.R. 6991), H1373 [8MR]

Depts. of HHS and State: formulate strategy to secure support from foreign countries, multilateral organizations, and others to facilitate development and commercialization of qualified pandemic or epidemic products (see H.R. 9303), H8507 [15NO]

Disasters: streamline sharing of information among Federal disaster assistance agencies, expedite delivery of life-saving assistance to survivors, speed recovery of communities, and protect privacy of survivors (see S. 4599), S3612 [21JY]

Diseases and disorders: end coronavirus lockdowns and vaccine mandates (see H.R. 9054), H8314 [29SE]

——— improve research and development of medical countermeasures for novel pathogens (see S. 3496), S220 [13JA]

——— making supplemental appropriations for coronavirus emergency response and relief (see H.R. 7007), H1421 [9MR]

——— making supplemental appropriations for coronavirus emergency response and relief (H.R. 7007), consideration (see H. Res. 973), H1421 [9MR]

——— mitigate effects of coronavirus pandemic on incentives for development of orphan drugs (see H.R. 8641), H7544 [2AU]

——— modernize process of accelerated approval of drugs for serious or life-threatening diseases or conditions (see S. 4446), S3075 [22JN]

——— prepare for, and respond to, existing viruses, emerging new threats, and pandemics (see S. 3799), S1118 [10MR]

——— prohibit Federal Government from limiting State access to key therapies and from prioritizing Federal contracts over State contracts relative to purchasing supplies to combat coronavirus pandemic (see S. 3440), S23 [4JA] (see H.R. 6832), H1145 [25FE]

——— prohibit transplant centers from discriminating against individual seeking organ due to whether individual is vaccinated against coronavirus (see H.R. 6534), H329 [1FE]

——— prohibit use of Federal funds for any system of records on religious accomodations relative to coronavirus vaccination requirement (see H.R. 6502), H301 [25JA]

——— prohibit vaccination mandates for coronavirus (see H.R. 6395), H193 [13JA]

——— protect against seasonal and pandemic influenza (see H.R. 9476), H8873 [8DE]

——— reauthorize program of grants and contracts for development of drugs for rare diseases and conditions (commonly known as ‘‘orphan drugs’’) (see H.R. 7640), H4712 [3MY]

——— support continued investment to complete development of HIV vaccine (see H. Res. 1506), H8709 [1DE]

——— terminate existing Federal coronavirus face covering and vaccine mandates (see H.R. 7423), H4396 [6AP]

District of Columbia: disapprove actions relative to school immunization requirements (see S.J. Res. 34), S351 [19JA]

——— nullify order of Mayor imposing vaccine entry requirement for certain establishments and facilities (see H.R. 6382), H77 [12JA]

——— prohibit use of Federal and local funds for coronavirus vaccine mandate in District of Columbia schools and repeal related legislation enacted by District of Columbia Council (see S. 4818), S4541 [12SE]

——— repeal coronavirus vaccination requirements (see S. 3514), S275 [18JA]

Dye, Christopher J.: tribute (see H. Res. 1108), H4920 [12MY]

FCC: establish protections for radio and television stations that provide advertising services to cannabis-related legitimate businesses and service providers for such businesses (see S. 4622), S3694 [26JY]

FDA: accelerate approval of products for serious or life-threatening diseases or conditions (see H.R. 6996), H1373 [8MR]

——— allow digital communication of prescribing information for drugs, including biological products (see H.R. 7559), H4453 [21AP]

——— allow for alternatives to animal testing for purposes of drug and biological product applications (see S. 5002), S5540 [29SE]

——— allow manufacturers and sponsors of drugs to use alternative testing methods to animal testing to investigate safety and effectiveness of biological products (see S. 4288), S2620 [19MY]

——— amend process informing persons submitting abbreviated application for new drug whether new drug is qualitatively or quantitatively same as listed drug (see H.R. 7032), H1422 [9MR]

——— authorize program to support adoption of, and improve development of, innovative approaches to pharmaceutical product design and manufacturing (see H.R. 6988), H1373 [8MR]

——— clarify reporting requirements for establishments within foreign country engaged in manufacture, preparation, propagation, compounding, or processing of active pharmaceutical ingredients (see H.R. 6483), H300 [25JA]

——— deem certain regulated products as drugs (see S. 4333), S2752 [26MY]

——— deny approval of new drug application for opioid analgesic drug on basis of such drug not being clincally superior to other commercially available drugs (see S. 4340), S2752 [26MY] (see H.R. 8586), H7405 [28JY]

——— enhance data reporting on clinical trial demographics and provide resources to improve access to clinical trials in underrepresented communities (see H.R. 6584), H946 [3FE]

——— establish additional authorities regarding conduct of pediatric investigations of molecularly targeted drugs to treat cancer (see S. 4215), S2493 [12MY] (see H.R. 6972), H1372 [8MR]

——— establish process to allow holders of abbreviated new generic drug applications to make labeling changes to include new or updated safety-related information (see H.R. 9011), H8220 [28SE]

——— expand certain authorities relative to recall of controlled substances to apply with respect to all drugs (see H.R. 6545), H330 [1FE]

——— express that process behind Operation Warp Speed should be integrated within operations (see H. Res. 876), H252 [19JA]

——— improve requirements for making determination of interchangeability of biological product and its reference product (see S. 6), S6778 [17NO]

——— make certain changes relative to approval of abbreviated applications for approval of new animal drugs (see H.R. 8857), H7881 [15SE]

——— modernize methods of authenticating controlled substances in pharmaceutical distribution supply chain (see H.R. 7653), H4713 [3MY]

——— modernize therapeutic equivalence rating determinations (see H.R. 7377), H4152 [4AP]

——— preserve access to abortion medications (see S. 4467), S3159 [23JN] (see H.R. 8405), H6706 [18JY]

——— prevent food shortages, including shortages of infant formula and certain medical foods (see S. 4256), S2586 [18MY] (see H.R. 7989), H5409 [8JN]

——— prohibit alteration, falsification, fabrication, destruction, omission, or removal of records or certain information required to be produced or maintained for drugs (see H.R. 6431), H252 [19JA]

——— promulgate rule relative to disclosure of side effects, contraindications, and effectiveness in prescription drug ads while also prohibiting distracting representations that detract from such disclosures (see H.R. 8289), H5935 [5JY]

——— provide for mandatory recall authority over regulated drugs and homeopathic products (see H.R. 6834), H1146 [25FE]

——— provide for period of exclusivity for first interchangeable biological products (see S. 4303), S2708 [25MY]

——— provide increased transparency in generic drug applications (see S. 4338), S2752 [26MY]

——— provide process to lock and suspend domain names used to facilitate online sale of drugs illegally (see S. 3984), S1910 [31MR]

——— publicly release summary of reasoning for approving drugs, biological products, and other therapies via accelerated approval process (see S. 4390), S2939 [14JN]

——— reaffirm preemptive authority relative to State laws that inhibit access to or use of any reproductive health product (see H. Res. 1434), H8395 [14OC]

——— reaffirm preemptive authority relative to State laws that inhibit access to or use of any reproductive health product (H. Res. 1434), adopt (see H. Res. 1529), H9982 [21DE]

——— reauthorize Critical Path Public-Private Partnerships (see S. 4152), S2358 [5MY] (see H.R. 7658), H4713 [3MY]

——— repeal authority to require that drugs be dispensed only upon prescription (see H.R. 6512), H307 [28JA]

——— report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices (see H.R. 6710), H1119 [11FE]

——— require foreign establishments engaged in production of drug or device to register whether or not drug or device undergoes further processing at separate location outside U.S. prior to being imported (see S. 3449), S117 [10JA]

——— require guidance on extending expiration dates for certain scarce drugs (see S. 3493), S189 [12JA] (see H.R. 7669), H4721 [6MY]

——— require manufacturers of dietary supplements to list dietary supplements (see S. 4090), S2154 [26AP]

——— require manufacturers to report medical device shortages, expedite review of essential medical devices, and grant authority to request information relative to security of U.S. medical product supply chain (see H.R. 7208), H3862 [24MR]

——— require more accurate reporting of abortion drug prescribing and related adverse events (see H.R. 6702), H1114 [9FE]

——— require prompt reports on marketing status by holders of approved applications for biological products (see S. 4302), S2708 [25MY] (see H.R. 7035), H1422 [9MR]

——— revise and extend user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products (see S. 4348), S2752 [26MY] (see S. 4535), S3308 [14JY] (see H.R. 7667), H4721 [6MY]

——— set forth limitations on exclusivity for orphan drugs (see S. 4185), S2449 [11MY]

——— shorten exclusivity period for brand name biological products (see H.R. 7828), H5174 [18MY]

——— strengthen authority relative to foreign drug facility inspections (see S. 3509), S220 [13JA]

——— strengthen requirements for postapproval studies for drugs approved using accelerated approval (see H.R. 6963), H1329 [7MR]

——— strengthen review and approval of drugs to treat rare diseases and conditions (see S. 4071), S2092 [7AP] (see H.R. 6888), H1207 [1MR]

Federal agencies and departments: prohibit from evaluating bids and proposals on basis of information relative to noncompliance with Federal contractor coronavirus vaccine mandate (see H.R. 6839), H1146 [25FE]

Federal aid programs: allow States and local educational agencies to use unspent coronavirus school emergency relief funds to purchase life-saving opioid antagonists and provide training and education to students and staff (see H.R. 8968), H8112 [22SE]

Federal Food, Drug, and Cosmetic Act: reauthorize provision relative to drugs containing single enantinomers (see S. 4378), S2910 [13JN]

Foreign countries: address foreign production of precursor chemicals used for illicit production of narcotics and psychotropic drugs and other controlled substances (see S. 4315), S2751 [26MY]

Forest Service: use Superfund toxic waste remediation authorities to address environmental damages caused by trespass cannabis cultivation and increase criminal penalties for use of illegal pesticides on Federal lands (see H.R. 9119), H8371 [30SE]

FTC: prevent unfair and deceptive acts or practices and dissemination of false information relative to pharmacy benefit management services for prescription drugs (see S. 4293), S2664 [24MY]

GAO: conduct study relative to coronavirus immunity resulting from prior infection, vaccination, or both (see S. 3809), S1118 [10MR]

——— issue report on nonprofit pharmaceutical organizations (see S. 4341), S2752 [26MY]

Government: prohibit from compiling or maintaining list of Federal employees who requested or been granted religious exemption to coronavirus vaccination requirement (see H.R. 7036), H1422 [9MR]

Government regulations: allow persons authorized to collect controlled substances for destruction through consumer return program to open and inspect packages and transport drugs to another location for destruction (see H.R. 6896), H1274 [2MR]

——— allow sponsors of certain new drug applications to rely on investigations conducted in certain foreign countries (see S. 3576), S523 [3FE]

Harris, Vice President: remove from position as head of Biden administration strategy to address root causes of migration (see H. Res. 1002), H3864 [24MR]

Health: address high cost of health care services, prescription drugs, and health insurance coverage (see H.R. 8588), H7405 [28JY]

——— amend laws relative to registration of opioid treatment programs to increase stakeholder input from relevant communities and ensure such programs are treating patients in need (see H.R. 8917), H8009 [20SE]

——— amend program for local substance use disorder services (see S. 3632), S647 [10FE]

——— ensure mental health and substance use disorder benefits are defined pursuant to external benchmarks based on nationally recognized standards (see H.R. 8886), H7964 [19SE]

——— express that fentanyl-related substances are a weapon of mass destruction and should be classified as such (see H. Res. 1327), H7727 [26AU]

——— extend certain public health programs (see S. 5244), S7134 [13DE] (see H.R. 9525), H9851 [14DE]

——— improve patient access to emerging medication therapies by clarifying scope of permitted communications between biopharmaceutical manufacturers and population health decision makers (see H.R. 7008), H1421 [9MR] (see H.R. 9297), H8507 [15NO]

——— prohibit consideration of coronavirus vaccination status in determining eligibility for organ donation or transplantation and in providing services to Medicare or Medicaid beneficiaries (see S. 3985), S1910 [31MR]

——— prohibit consideration of race, color, religion, sex, national origin, age, disability, vaccination status, veteran status, political ideology, or speech in determining eligibility for monoclonal antibody doses (see S. 3974), S1910 [31MR]

——— provide for designation of biological products as qualified infectious disease products (see S. 3478), S159 [11JA]

——— provide for lower prices through drug price negotiation (see H.R. 7497), H4438 [11AP]

——— provide for national uniformity for reproductive health products (see S. 4748), S3862 [2AU]

——— require certain drug manufacturers entering into settlement agreements for violations of law to make supplemental payments to increase medical research funding (see S. 5322), S9625 [20DE] (see H.R. 9687), H10055 [22DE]

——— review and improve domestic biopharmaceutical manufacturing capabilities and public health and medical preparedness and response (see S. 3553), S496 [2FE]

Immigration: request President and Dept. of Homeland Security to transmit copies of all documents in their possession referring or relative to certain aspects of U.S. border policies (see H. Res. 928), H1124 [15FE]

Inflation Reduction Act: repeal Medicare prescription drug price control provisions (see S. 4953), S5051 [27SE]

Information technology: prohibit delivery of opioids by means of dark web (see S. 3782), S1059 [8MR] (see H.R. 7300), H4006 [30MR]

Infrastructure Investment and Jobs Act: repeal provision relative to advanced impaired driving technology motor vehicle safety standard (see S. 4647), S3743 [27JY]

Insurance: allow membership organizations to offer health insurance to members through health share pools, including across State lines, regardless of employment relationship or pre-existing condition (see S. 5303), S9625 [20DE]

——— establish new coverage and payment rules for certain coronavirus diagnostic tests and related items and service (see H.R. 6851), H1146 [25FE]

——— establish requirements relative to cost-sharing for certain insulin products (see H.R. 6833), H1145 [25FE]

——— establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), consideration (see H. Res. 1017), H4071 [31MR]

——— establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), consideration of Senate amendment (see H. Res. 1404), H8313 [29SE]

——— establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), correction in enrollment (see S. Con. Res. 45), S5543 [29SE]

——— require group health plans and group or individual health insurance coverage to provide coverage for over-the-counter contraceptives (see S. 4347), S2752 [26MY] (see H.R. 7894), H5219 [27MY]

——— require health insurance providers to issue notices relative to prescription drug refills to individuals residing in emergency areas during emergency periods (see H.R. 8270), H5929 [1JY]

——— require out-of-network coverage for qualified individuals participating in approved clinical trials (see H.R. 8546), H7255 [27JY]

International Day Against Drug Abuse and Illicit Trafficking: designate (see S. Res. 685), S3031 [21JN] (see H. Res. 1175), H5546 [14JN]

Law enforcement: prohibit deceptive sale of fentanyl (see S. 4984), S5225 [28SE]

——— provide enhanced capabilities to combat transnational criminal cartels (see H.R. 9312), H8541 [16NO]

——— provide for requirements for electronic-prescribing for controlled substances under group health plans and group and individual health insurance coverage (see H.R. 8988), H8119 [26SE]

——— increase number of cannabis manufacturers registered under Controlled Substances Act for legitimate research purposes and allow VA health care providers to recommend federally-approved cannabis clinical trials (see H.R. 9679), H10055 [22DE]

——— streamline, coordinate, and expand research and foster increased communication between doctors and patients relative to cannabidiol and other marijuana components and their medical benefits (see H.R. 8454), H7065 [21JY]

Medicaid: codify value-based purchasing arrangements and reforms relative to price reporting under such arrangements (see H.R. 7389), H4152 [4AP]

——— provide States with option to provide medical assistance to individuals between ages of 22 and 64 for inpatient services to treat substance use disorders at certain facilities (see H.R. 7156), H3852 [18MR]

——— remove coverage exclusion for inmates in custody pending disposition of charges (see H.R. 6636), H1013 [7FE]

Medical devices: strengthen medical device supply chains (see S. 3834), S1153 [14MR]

Medicare: direct Sec. of HHS to provide documentation to House of Representatives relative to negotiation of prices for prescription drugs under prescription drug program (see H. Res. 1284), H7170 [26JY]

——— ensure Medicare-only PACE program enrollees have choice of prescription drug plans under part D (see S. 5106), S6740 [16NO]

——— establish cap on costs for covered prescription drugs (see S. 3615), S612 [9FE]

——— establish improved Medicare for All national health insurance program (see S. 4204), S2492 [12MY]

——— establish Medicare for America program to provide comprehensive health insurance coverage for all U.S. citizens (see H.R. 9655), H9983 [21DE]

——— establish minimum amount of price concessions for insulin to be passed through to beneficiaries at point-of-sale (see H.R. 6757), H1129 [18FE]

——— exclude independent agents and brokers from requirement to record calls with beneficiaries under Medicare Advantage and prescription drug benefit programs (see S. 5149), S6905 [30NO]

——— expand eligibility for incentives under health professional shortage area bonus program to practitioners furnishing mental health and substance use disorder services (see S. 5042), S5542 [29SE]

——— improve access to opioid use disorder treatment services (see S. 4618), S3694 [26JY]

——— make premium and cost-sharing subsidies available to low-income part D beneficiaries residing in Puerto Rico or other U.S. territories (see S. 3778), S1059 [8MR]

——— promote access to opioid treatments and require coverage of medication assisted treatment, overdose reversal medications, and recovery support services by health plans without cost-sharing requirements (see S. 5008), S5540 [29SE]

——— protect part D six protected classes (see H. Res. 1390), H8113 [22SE]

——— provide for cap on beneficiary liability under part D (see S. 4011), S2040 [6AP]

——— provide outreach and reporting on opioid use disorder treatment services furnished by opioid treatment programs (see H.R. 8884), H7964 [19SE]

——— provide pharmacy reimbursement for coronavirus-related and future emergency services (see H.R. 7213), H3863 [24MR]

——— provide review process for adverse national coverage determinations relative to drug coverage of certain new, innovative treatments (see H.R. 9358), H8647 [29NO]

——— remedy election revocations relative to administration of coronavirus vaccines (see S. 4899), S4856 [20SE]

——— require complete and accurate data submissions from Medicare Advantage organizations offering plans under Part C to improve transparency (see H.R. 9019), H8221 [28SE]

Medicare/Medicaid: prohibit any conditions of participation that include vaccine or drug mandate (see H.R. 6414), H216 [18JA]

——— provide coverage of prescription digital therapeutics for treatment of mental health and substance use disorders (see S. 3791), S1118 [10MR] (see H.R. 7051), H1423 [9MR]

——— require drug and biological product manufacturers to include truthful and non-misleading pricing information in any direct-to-consumer advertising (see H.R. 7529), H4443 [14AP]

Mental health: address high prevalence of mental health conditions and substance use disorders by making historic financial investments and acknowledging mental health as priority equal to physical health (see S. Res. 518), S786 [17FE]

——— clarify applicability of certain parity provisions to mental health and substance use disorder telehealth benefits (see H.R. 8229), H5918 [24JN]

——— provide for mental health and substance use disorder services in response to public health emergencies (see S. 3476), S159 [11JA]

——— strengthen parity in mental health and substance use disorder benefits (see S. 4616), S3694 [26JY] (see H.R. 8512), H7169 [26JY]

Methadone: revise Dept. of HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs to include testing for methadone use and require Dept. of Transportation to include testing for methadone use in drug tests (see H.R. 9599), H9902 [15DE]

Mexico: express concern about economic and security conditions and reaffirm interest in mutually beneficial relations based on shared interests on security, economic prosperity, and democratic values (see S. Res. 704), S3270 [13JY]

National Academies of Sciences, Engineering, and Medicine: conduct study relative to coronavirus immunity resulting from prior infection, vaccination, or both (see S. 3831), S1153 [14MR]

National Adult Hepatitis B Vaccination Awareness Day: designate (see S. Res. 602), S2219 [28AP] (see H. Res. 1072), H4608 [28AP]

National Fentanyl Awareness Day: designate (see S. Res. 624), S2381 [9MY] (see H. Res. 1102), H4797 [10MY]

National Guard: prohibit any requirement that members receive vaccination against coronavirus (see S. 4499), S3200 [11JY]

National HIV/AIDS and Aging Awareness Day: support goals and ideals (see H. Res. 1370), H7965 [19SE]

National Institute for Occupational Safety and Health: educate workplace professionals on prevention of impairment from cannabis, opioids, and other drugs, and risks resulting from individuals working while impaired (see H.R. 8591), H7537 [29JY]

National Recovery Month: designate (see S. Res. 778), S4857 [20SE]

NIH: establish Advanced Research Projects Authority for Health (see S. 3819), S1119 [10MR]

——— establish or continue research program to advance discovery and preclinical development of medical products for priority virus families and other viral pathogens with significant pandemic potential (see S. 3489), S189 [12JA]

——— take certain steps to increase clinical trial diversity (see S. 5268), S7252 [15DE] (see H.R. 7845), H5207 [19MY]

Office of National Drug Control Policy: modify authority (see S. 3617), S612 [9FE]

Older Americans Mental Health Awareness Day: designate (see S. Res. 657), S2752 [26MY]

OSHA: clarify scope of authority for emergency temporary standards relative to mandatory coronavirus vaccination or testing (see S. 3555), S496 [2FE]

——— prohibit enforcement of any drug or vaccine mandates (see H.R. 7127), H3826 [17MR]

——— provide that rule relative to mandatory vaccine mandates for certain businesses shall have no force or effect (see S. 3461), S118 [10JA]

Patent and Trademark Office: improve process to challenge validity of patents through Patent Trial and Appeal Board (see S. 4417), S3003 [16JN]

Patents: establish interagency task force between Patent and Trademark Office and FDA for sharing information and providing technical assistance relative to patents (see S. 4430), S3003 [16JN]

Patient Protection and Affordable Care Act: ensure tax payer funds for health insurance coverage are available only to authorized individuals (see H.R. 8441), H6921 [20JY]

Pharmaceuticals: clarify Federal Right To Try laws apply to schedule 1 substances for which phase 1 clinical trial has been completed and provide access to eligible patients to such substances (see S. 4575), S3542 [20JY] (see H.R. 8440), H6921 [20JY]

——— increase transparency of research costs (see S. 4037), S2091 [7AP] (see H.R. 7474), H4432 [7AP]

——— prohibit manufacturers from interfering with therapeutically equivalent or interchangeable substitutions by health care providers to limit competition from generic drug or biosimilar biological products (see H.R. 7473), H4432 [7AP]

Political ethics: prohibit former employees of certain health agencies from serving on board of entities involved in development and research of covered vaccines (see H.R. 9708), H10550 [3JA]

Postal Service: provide authority for small cultivators of marijuana and small manufacturers of marijuana products to ship marijuana and marijuana products using the mail (see H.R. 8825), H7841 [14SE]

Prematurity Research Expansion and Education for Mothers Who Deliver Infants Early (PREEMIE) Act: reauthorize (see S. 5336), S9778 [21DE]

Rare Disease Day: designate (see H. Res. 948, 952), H1176 [28FE]

Religion: prohibit imposition of certain substantial burdens relative to coronavirus vaccine mandates on religious exercise (see S. 4163), S2381 [9MY]

SBA: ensure that certain entrepreneurial development services are made available to cannabis-related legitimate businesses and service providers (see S. 5131), S6779 [17NO]

Schools: prohibit provision of Federal funds to local educational agencies that impose or enforce coronavirus vaccine mandate on students at schools served by such agencies (see H.R. 9280), H8433 [7NO]

Senate: prohibit imposition of vaccination, testing, and masking requirements relative to coronavirus for Senate Pages (see S. Res. 631), S2493 [12MY]

Small business: permit access to financial capital sources for investment in and financing of cannabis-related businesses and create safe harbor for securities exchanges to list securities of cannabis-related businesses (see H.R. 8200), H5877 [23JN]

Social Security: clarify manufacturer transparency reporting requirements for certain transfers used for educational purposes (see H.R. 9378), H8707 [1DE]

Stepanov, Vitaly: relief (see H.R. 6822), H1140 [22FE]

Stepanova, Yuliya: relief (see H.R. 6822), H1140 [22FE]

Substance Abuse and Mental Health Services Administration: extend residential treatment program for pregnant and postpartum women pilot program (see S. 5285), S7252 [15DE]

——— require States receiving block grant for substance use prevention and treatment to describe efforts to promote work to improve mental health and well-being (see H.R. 8523), H7254 [27JY]

——— study certain exemptions for treatment of opioid use disorder through treatment programs during coronavirus emergency and modernize process for obtaining methadone (see S. 3629), S647 [10FE]

Syria: recognize anniversary of Syrian revolution against Bashar al-Assad (see H. Res. 985), H3743 [15MR]

Tardive Dyskinesia Awareness Week: designate (see H. Res. 1107), H4861 [11MY]

Taxation: allow deductions and credits relative to expenditures in connection with marijuana sales conducted in compliance with State law (see H.R. 9702), H10547 [30DE]

——— prohibit deduction for prescription drug advertising and promotional expenses (see H.R. 6392), H193 [13JA]

——— provide extended expensing of pharmaceutical manufacturing property and production tax credit for pharmaceuticals and active pharmaceutical ingredients (see H.R. 7166), H3853 [18MR]

——— provide tax credit for domestic medical and drug manufacturing and advanced medical manufacturing equipment (see H.R. 7410), H4191 [5AP]

——— raise health savings accounts contributions limit, remove requirement to maintain high deductible coverage relative to such accounts, and include drugs as qualified medical expenses (see H.R. 6474), H294 [21JA]

——— strike provision of American Opportunity Tax Credit that denies credit to students with felony drug convictions (see S. 5126), S6779 [17NO] (see H.R. 9331), H8587 [17NO]

Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: extend (see S. 5167), S6941 [1DE] (see H.R. 9595), H9902 [15DE]

Trucking industry: exempt commercial truck drivers from Canada or Mexico seeking to temporarily enter U.S. for business through land port of entry from any coronavirus vaccination requirement (see S. 3701), S786 [17FE] (see H.R. 6809), H1139 [22FE]

21st Century Cures Act: amend State Opioid Response Grants program (see H.R. 7189), H3858 [21MR]

U.N. Commission on Narcotic Drugs: encourage U.S. representative to use voice, vote, and influence of U.S. to deschedule cannabis from Schedule I of Single Convention of Narcotic Drugs (see H. Con. Res. 81), H3858 [21MR]

U.S. Anti-Doping Agency: modify authority (see S. 3617), S612 [9FE]

U.S. Customs and Border Protection: evaluate implementation of legislation to process certain international mail shipments and advance electronic information on international mail shipments to target opioid shipments (see S. 5290), S7252 [15DE]

U.S. service academies: prohibit denial of graduation, dismissal, or assessment of repayment claims for cadets and midshipmen who refuse to get coronavirus vaccine (see S. 4304), S2708 [25MY] (see H.R. 7890), H5219 [27MY]

Vaccines: hold vaccine manufacturers liable for injuries caused by vaccines subject to public mandate (see H.R. 9366), H8673 [30NO]

van Hoek, Jan: relief (see H.R. 9694), H10531 [23DE]

Veterans: ensure servicemembers granted general discharge under honorable conditions on sole basis of failure to obey lawful order to receive coronavirus vaccine is eligible for certain educational assistance (see H.R. 6671), H1112 [9FE]

Voting: ensure that right to vote shall not be impaired due to vaccination status (see S. 3485), S189 [12JA] (see H.R. 6558), H916 [2FE]

World Tuberculosis Day: support goals (see S. Res. 569), S1867 [30MR]

Cloture motions

Insurance: establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), S5148 [28SE]

——— establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), motion to proceed, S4955 [22SE], S5045 [27SE]

Cost Estimates

Inflation Reduction Act (H.R. 5376): CBO, H7662 [12AU]

Mental Health Matters Act (H.R. 7780): CBO, E1007 [30SE]

Prevent Exposure to Narcotics and Toxics (PREVENT) Act (H.R. 5274): CBO, E667 [23JN]

Court decisions

Tarahrick Terry v. U.S.: Supreme Court, H8627 [29NO]

Essays

State of the Union: Samantha Haselman, S1152 [14MR]

Letters

Affordable Insulin Now Act: Bob Carlstrom, AMAC Action (organization), H4039 [31MR]

——— James P. Gelfand, ERISA Industry Committee (organization), H4040 [31MR]

——— Kevin Kuhlman, National Federation of Independent Business, H4039 [31MR]

——— Partnership for Employer-Sponsored Coverage (organization), H4039 [31MR]

——— Tom Schatz, Council for Citizens Against Government Waste, H4039 [31MR]

Countering Assad’s Proliferation Trafficking and Garnering of Narcotics (CAPTAGON) Act: Representative Meeks, Committee on Foreign Affairs (House), H7907 [19SE]

——— Representative Nadler, Committee on the Judiciary (House), H7907 [19SE]

DEA authority to perform arrests or detainments in foreign countries: Jason M. Thurman, DEA, E591 [8JN]

Dept. of Justice Justice and Mental Health Collaboration Program reauthorization: Loretta Rush, Conference of Chief Justices and Karl Hade, Conference of State Court Administrators, H8620 [29NO]

——— Patrick Yoes, National Fraternal Order of Police, H8620 [29NO]

——— several organizations, H8621 [29NO]

Ensure equitable treatment of covered entities and pharmacies participating in 340B drug discount program: several Representatives, H5325 [7JN]

Inflation Reduction Act: several economists, H7697 [12AU]

Inflation Reduction Act drug price control policies: House of Representatives GOP Doctors Caucus, H7682 [12AU]

Inflation Reduction Act prescription drug reforms: Dan Leonard, Association of Accessible Medicines Biosimilars Council, H7677 [12AU]

Inflation Reduction Act provisions impact on launch prices of new drugs and introduction of new generic drugs: Phillip L. Swagel, CBO, H7649, H7665 [12AU]

Marijuana Opportunity Reinvestment and Expungement (MORE) Act: several organizations, H4105 [1AP]

Medical Marijuana Research Act: Representative Nadler, Committee on the Judiciary (House), E371 [7AP]

——— Representative Pallone, Committee on Energy and Commerce (House), E371 [7AP]

Mental Health Matters Act: Edwin S. Jayne, American Federation of State, County and Municipal Employees, H8241 [29SE]

——— Kathleen Minke, National Association of School Psychologists, H8240 [29SE]

——— Marc Egan, National Education Association, H8240 [29SE]

——— several mental health organizations, H8241 [29SE]

Prevent Exposure to Narcotics and Toxics (PREVENT) Act: Representative Bennie G. Thompson, Committee on Homeland Security (House), H5694 [21JN]

——— Representative Neal, Committee on Ways and Means (House), H5694 [21JN]

Request Dept. of State review and determine whether Syria meets criteria to be defined as ‘‘major illicit drug producing country’’ or ‘‘major drug-transit country’’: Representatives Hill and Boyle and Senator Marshall, H7907 [19SE]

Restoring Hope for Mental Health and Well-Being Act: Representative Nadler, Committee on the Judiciary (House), H5774 [22JN]

——— Representative Pallone, Committee on Energy and Commerce (House), H5774 [22JN]

Revise and extend FDA user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products: Xavier Becerra, Sec. of HHS, S5171, S5172, S5173, S5174, S5175, S5176, S5177 [28SE]

Terry Technical Correction Act: Jeri Williams, Major Cities Chiefs Association, H8627 [29NO]

——— several attorneys general, H8626 [29NO]

Lists

Committee on Taxation (Joint) staff working on H.R. 5376, Inflation Reduction Act, S4954 [22SE]

Congressional Budget Office staff working on H.R. 5376, Inflation Reduction Act, S4954 [22SE]

Organizations opposing H.R. 5376, Inflation Reduction Act, H7678 [12AU]

Votes recorded by proxy on Bucshon motion to recommit H.R. 6833, Affordable Insulin Now Act, H4054 [31MR]

Votes recorded by proxy on Demings amendment to H.R. 7666, Restoring Hope for Mental Health and Well-Being Act, H5805 [22JN]

Votes recorded by proxy on Eshoo amendment to H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act, H5808 [22JN]

Votes recorded by proxy on Gottheimer amendment to H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4110 [1AP]

Votes recorded by proxy on Griffith amendment to H.R. 7666, Restoring Hope for Mental Health and Well-Being Act, H5807 [22JN]

Votes recorded by proxy on H. Res. 973, consideration of H.R. 7007, supplemental appropriations for coronavirus emergency response and relief, H1394 [9MR]

Votes recorded by proxy on H. Res. 1017, consideration of H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4033 [31MR]

Votes recorded by proxy on H. Res. 1017, consideration of H.R. 6833, Affordable Insulin Now Act, H4033 [31MR]

Votes recorded by proxy on H. Res. 1191, consideration of H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act, H5752 [22JN]

Votes recorded by proxy on H. Res. 1191, consideration of H.R. 7666, Restoring Hope for Mental Health and Well-Being Act, H5752 [22JN]

Votes recorded by proxy on H. Res. 1316, consideration of Senate amendment to H.R. 5376, Inflation Reduction Act, H7577 [12AU]

Votes recorded by proxy on H. Res. 1396, consideration of H.R. 7780, Mental Health Matters Act, H8179 [28SE]

Votes recorded by proxy on H. Res. 1529, adopt H. Res. 1434, reaffirm FDA preemptive authority relative to State laws that inhibit access to or use of any reproductive health product, H9972 [21DE]

Votes recorded by proxy on H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4115 [1AP]

Votes recorded by proxy on H.R. 4133, Caribbean Basin Security Initiative appropriations, U.S.-Caribbean security partnership enhancement, and disaster resilience prioritization, H4559 [27AP]

Votes recorded by proxy on H.R. 5274, Prevent Exposure to Narcotics and Toxics (PREVENT) Act, H6287 [13JY]

Votes recorded by proxy on H.R. 5455, Terry Technical Correction Act, H8644 [29NO]

Votes recorded by proxy on H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act, H5809 [22JN]

Votes recorded by proxy on H.R. 5657, Medical Marijuana Research Act, H4144 [4AP]

Votes recorded by proxy on H.R. 6493, Campus Prevention and Recovery Services for Students Act, H5856 [23JN]

Votes recorded by proxy on H.R. 6833, Affordable Insulin Now Act, H4055 [31MR]

Votes recorded by proxy on H.R. 7666, Restoring Hope for Mental Health and Well-Being Act, H5807 [22JN]

Votes recorded by proxy on H.R. 7667, revise and extend FDA user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, H5403 [8JN]

Votes recorded by proxy on H.R. 7780, Mental Health Matters Act, H8268 [29SE]

Votes recorded by proxy on H.R. 8454, Medical Marijuana and Cannabidiol Research Expansion Act, H7146 [26JY]

Votes recorded by proxy on Lamb amendment to H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4111 [1AP]

Votes recorded by proxy on Latta motion to recommit H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4115 [1AP]

Votes recorded by proxy on McClain motion to recommit H.R. 7780, Mental Health Matters Act, H8267 [29SE]

Votes recorded by proxy on Pallone amendment to H.R. 7666, Restoring Hope for Mental Health and Well-Being Act, H5804, H5805 [22JN]

Votes recorded by proxy on previous question to H. Res. 973, consideration of H.R. 7007, supplemental appropriations for coronavirus emergency response and relief, H1393 [9MR]

Votes recorded by proxy on previous question to H. Res. 1017, consideration of H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4032 [31MR]

Votes recorded by proxy on previous question to H. Res. 1017, consideration of H.R. 6833, Affordable Insulin Now Act, H4032 [31MR]

Votes recorded by proxy on previous question to H. Res. 1191, consideration of H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act, H5751 [22JN]

Votes recorded by proxy on previous question to H. Res. 1191, consideration of H.R. 7666, Restoring Hope for Mental Health and Well-Being Act, H5751 [22JN]

Votes recorded by proxy on previous question to H. Res. 1316, consideration of Senate amendment to H.R. 5376, Inflation Reduction Act, H7575 [12AU]

Votes recorded by proxy on previous question to H. Res. 1396, consideration of H.R. 7780, Mental Health Matters Act, H8178 [28SE]

Votes recorded by proxy on Raskin amendment to H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4112 [1AP]

Votes recorded by proxy on Rodgers amendment to H.R. 7666, Restoring Hope for Mental Health and Well-Being Act, H5806 [22JN]

Votes recorded by proxy on S. 2796, Rural Area Opioid Prevention Act, H8778 [6DE]

Votes recorded by proxy on S. 3846, Justice and Mental Health Collaboration Program reauthorization, H8644 [29NO]

Votes recorded by proxy on Senate amendment to H.R. 5376, Inflation Reduction Act, H7704 [12AU]

Messages

National Emergency Relative to Global Illicit Drug Trade: President Biden, S7099 [12DE], H9684 [12DE]

Motions

Centers for Medicare & Medicaid Services: disapprove rule entitled ‘‘Medicare and Medicaid Programs; Omnibus COVID–19 Health Care Staff Vaccination’’ (S.J. Res. 32), S874 [1MR]

Dept. of HHS: support behavioral needs of students and youth, invest in school-based behavioral workforce, and ensure access to mental health and substance use disorder benefits (H.R. 7780), H8252 [29SE]

Dept. of Justice: reauthorize Justice and Mental Health Collaboration Program (S. 3846), S7185 [14DE]

Insurance: establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), S4955 [22SE], S5037 [27SE], S5148 [28SE], H4046 [31MR], H8346 [30SE]

Notices

Estimated budget effects of H.R. 5657, Medical Marijuana Research Act, H4152 [4AP]

Estimated budget effects of H.R. 7667, revise and extend FDA user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, H5330 [7JN]

Estimated budget effects of H.R. 8454, Medical Marijuana and Cannabidiol Research Expansion Act, H7163 [26JY]

Papers

Evidence Base on the Impact of Price Controls on Medical Innovation: Tomas J. Philipson and Troy Durie, University of Chicago, H7671–H7673 [12AU]

Press releases

Attorney General Frosh Calls on Congress To Clarify First Step Act and Apply Fair Sentencing Reforms to Low Level Drug Offenses: Brian E. Frosh, Maryland Attorney General, H8629 [29NO]

Nonpartisan Tax Scorekeeper—Average Working Family Is More Likely To Be Worse Off Than Better Off Under Democrat’s Tax Plan: Committee on Ways and Means (House) Republican Staff, H7663 [12AU]

U.S. Overdose Deaths in 2021 Increased Half as Much as in 2020—But Are Still Up 15 Percent: CDC, H8747 [5DE]

Remarks in House

Abortion: prohibit award of Federal funds to higher education institutions that host or are affiliated with student-based service site that provides abortion drugs or abortions to students or employees (H.R. 4607), H227 [19JA]

Armed Forces: prohibit any requirement that members be vaccinated against coronavirus (H.R. 3860), H8782 [6DE]

——— prohibit denial of any Federal education benefit to which members are entitled solely on basis of refusal to receive coronavirus vaccine, H57 [12JA]

——— reinstate servicemembers involuntarily separated solely due to refusal to receive vaccination against coronavirus, H8058, H8059 [21SE]

——— reinstate servicemembers who failed to obey order to receive coronavirus vaccine, H5981 [13JY]

Bedford, PA: anniversary of Letrent’s Pharmacy, E158 [18FE]

Biden, President: evaluation of administration, H68 [12JA], H208–H214 [18JA], H283–H286 [20JA], H899–H905 [2FE], H3817–H3822 [17MR], H3974 [30MR], H4847 [11MY], H8324 [30SE], E858 [16AU]

——— evaluation of administration relative to economy, H1292–H1294 [3MR], H7413 [29JY]

——— evaluation of administration relative to immigration, H22 [11JA], H47 [12JA], H240–H246 [19JA], H271 [20JA], H347, H909–H912 [2FE], H945 [3FE], H1071 [8FE], H1107 [9FE], H1258, H1270–H1273 [2MR], H1296 [3MR], H1305, H1324 [7MR], H3735 [15MR], H3823 [17MR], H3832, H3846 [18MR], H4003 [30MR], H4066–H4070 [31MR], H4129, H4147 [4AP], H4158, H4161 [5AP], H4202, H4384–H4388, H4391–H4395 [6AP], H4424–H4429 [7AP], H4519, H4568–H4573 [27AP], H4604–H4606 [28AP], H4855 [11MY], H4960 [13MY], H4976 [16MY], H5095 [17MY], H5172 [18MY], H5241 [7JN], H5337, H5405 [8JN], H5556, H5600, H5602 [15JN], H5738, H5818, H5819 [22JN], H5835 [23JN], H6509 [13JY], H6512, H6514 [14JY], H6628 [15JY], H6879 [19JY], H6909, H6910, H6913 [20JY], H7082 [26JY], H7240 [27JY], H7747 [13SE], H7791 [14SE], H7846 [15SE], H7886, H7947, H7948 [19SE], H7974 [20SE], H8021, H8053, H8058, H8061 [21SE], H8228, H8291, H8306, H8310 [29SE], H8358 [30SE], H8549, H8556 [17NO], H8677, H8705 [1DE], H8724 [2DE], H8807, H8812, H8821 [7DE], H9686 [12DE], H9695, H9713–H9715 [13DE], H9742, H9750, H9850 [14DE], H9860, H9885 [15DE], H9923 [21DE]

——— State of the Union Message, H1258 [2MR], H1295 [3MR]

Business and industry: address market consolidation in pharmaceutical industry, H1214 [2MR]

California: tribute to 36th Congressional District pharmacies and health centers for efforts to distribute coronavirus vaccines to underserved communities, E390 [18AP]

Caribbean nations: authorize appropriations for Caribbean Basin Security Initiative, enhance U.S.-Caribbean security partnership, and prioritize disaster resilience (H.R. 4133), H4543–H4545 [27AP]

CDC: conduct public education campaign that raises public awareness of dangers of synthetic opioids and explains services available relative to opioid treatment, H5791 [22JN]

Centers for Medicare & Medicaid Services: decision to restrict coverage of Biogen, Inc., Alzheimer’s disease drug, H4577 [28AP]

——— implement drug manufacturer discount program, H7702 [12AU]

Clark, MO: Primrose Hill Adult & Teen Challenge recovery center recipient of Champion for Drug-Free Missouri Award, E506 [16MY]

Committee on Energy and Commerce (House): tribute to staff working on H.R. 5376, Inflation Reduction Act, H7690 [12AU]

Congress: accomplishments of 117th Congress, H8104 [22SE]

Consumers: lower out of pocket spending, protect access to new cures and medications, strengthen transparency, and encourage competition (H.R. 19), H4035–H4038, H4043 [31MR], H7681, H7686 [12AU], E362 [6AP]

Coronavirus: direct FEMA to assist States and local governments with distribution and tracking of vaccines and direct Dept. of HHS to carry out national program to oversee collection and maintenance of data on vaccinations (H.R. 330), H1318 [7MR]

——— direct FEMA to assist States and local governments with distribution and tracking of vaccines and direct Dept. of HHS to carry out national program to oversee collection and maintenance of data on vaccinations (H.R. 936), H7954 [19SE]

Courts: assessment of liability protections available to individuals and entitities in pharmaceutical, social media, and political industries, H6947 [21JY]

Crime: address nationwide increase in violent crime, H969 [4FE]

——— combat trafficking of illicit fentanyl, H1089, H1090 [9FE], H7080 [26JY], E128 [8FE], E139 [11FE]

——— combat trafficking of illicit fentanyl and other synthetic drugs, H12, H37–H39 [11JA], H9693 [13DE]

——— reduce threshold for mandatory minimum penalties for certain fentanyl-related offenses (H.R. 5694), H1064 [8FE]

DEA: authority to perform arrests or detainments in foreign countries, E591 [8JN], E1081 [25OC]

——— clarify process for registrants to exercise due diligence upon discovering suspicious orders, H5791 [22JN]

——— delay implementation of separate registration requirement for dispensing narcotic drugs categorized in schedules with lower potential for abuse that are intended for maintenance or detoxification treatment, H5793–H5795 [22JN]

——— eliminate separate registration requirement for dispensing narcotic drugs categorized in schedules with lower potential for abuse that are intended for maintenance or detoxification treatment, H5777 [22JN]

——— include fentanyl-related substances under schedule I of Controlled Substances Act, designating they have high potential for abuse and no medical use (H.R. 6946), H7886 [19SE]

——— include fentanyl-related substances under schedule I of Controlled Substances Act, designating they have high potential for abuse and no medical use (S. 339), H39 [11JA]

——— make permanent scheduling of fentanyl-related substances (H.R. 6184), H352, H353, H901, H902, H903 [2FE], H979, H982 [7FE], H1021, H1062 [8FE], H4094 [1AP], H8083 [22SE], H8174–H8177 [28SE]

——— provide for life imprisonment for certain offenses involving fentanyl (H.R. 6439), H901 [2FE], H1063 [8FE]

Democratic Party: national agenda, H3817–H3822 [17MR], H6913–H6916 [20JY], H7238 [27JY]

Dept. of Defense: coronavirus vaccine mandate, H8821 [7DE]

——— establish grant program to study use of psychedelic treatments for veterans and servicemembers with post-traumatic stress disorder, H6264 [13JY]

——— require bi-monthly report on number of religious and medical exemptions for coronavirus vaccine mandate, H6263 [13JY]

Dept. of Education: provide grants for institutions of higher education to prevent alcohol and substance misuse (H.R. 6493), H5842–H5845 [23JN], E662 [23JN]

Dept. of HHS: allow women greater access to safe and effective oral contraceptive drugs intended for routine use, H6938 [21JY]

——— anniversary of 340B Drug Pricing Program, H1024 [8FE], H5325–H5330 [7JN], H5451 [13JN], E595 [8JN], E608 [9JN]

——— authorize grants to develop strategic response plans relative to opioid crisis and require providers prescribing opioids for certain patients to also prescribe opioid overdose reversal drugs (H.R. 5224), H1324 [7MR], H9850 [14DE]

——— ensure maternal mental health hotline officials consult State and local officials who administer programs serving pregnant and postpartum individuals, H5782 [22JN]

——— enter agreement with National Academies of Sciences, Engineering, and Medicine to conduct study on quality and effectiveness of covered recovery housing in the U.S., H5781 [22JN]

——— establish Advanced Research Projects Agency-Health, H1413 [9MR]

——— establish Advanced Research Projects Agency-Health (H.R. 5585), H5633 [16JN], H5795–H5803 [22JN], H5834 [23JN]

——— establish Advanced Research Projects Agency-Health (H.R. 5585), consideration (H. Res. 1191), H5745–H5752 [22JN], E659 [23JN]

——— establish Fair Price Negotiation Program to reduce drug prices, penalize companies that refuse to negotiate, and prevent excessive price increases and establish out-of-pocket caps for Medicare (H.R. 3), H188 [13JA], H248 [19JA], H1068 [8FE], H4044, H4060 [31MR]

——— establish programs to address addiction and overdoses caused by illicit fentanyl and other opioids (H.R. 2366), H39 [11JA], H1157 [28FE]

——— improve inspections of foreign drug manufacturing establishments, E594 [8JN]

——— increase uptake of collaborative care model for treating behavioral health, H5778 [22JN]

——— make certain improvements to block grants for substance use prevention, treatment, and recovery services, H5775 [22JN]

——— prohibit from restricting direct access by health care facilities to coronavirus monoclonal antibody therapies (H.R. 5663), H182 [13JA]

——— provide better protections and support for children raised by grandparents or other kinship families outside foster care system due to parental drug or alcohol abuse (H.R. 2747), H7976 [20SE]

——— reauthorize and expand State Opioid Response Grants program, H5791 [22JN]

——— reauthorize certain programs relative to mental health and substance use disorders (H.R. 7666), H5633 [16JN], H5752–H5795, H5810, H5811 [22JN], H5835 [23JN], H5885 [24JN], H6876 [19JY], H8083 [22SE]

——— reauthorize certain programs relative to mental health and substance use disorders (H.R. 7666), consideration (H. Res. 1191), H5745–H5752 [22JN], E659 [23JN]

——— reauthorize certain programs relative to mental health and substance use disorders (H.R. 7666), corrections in engrossment, H5810 [22JN]

——— reauthorize grant program for screening, assessment, and treatment services for maternal mental health and substance use disorders, H5747, H5779 [22JN]

——— require Inspector General investigation and report on Vaccine Adverse Event Reporting System (H.R. 7308), H4158 [5AP]

——— require report to study rates of suicidal behaviors among children and adolescents with chronic illnesses, including substance use disorders, autoimmune disorders, and heritable blood disorders, H5787 [22JN]

——— revise opioid treatment program admission criteria to eliminate requirement that patients have been addicted for at least 1 year prior to being admitted for treatment, H5779 [22JN]

Dept. of Homeland Security: provide training for U.S. Customs and Border Protection personnel on use of containment devices to prevent secondary exposure to fentanyl and other potentially lethal substances (H.R. 5274), H5693–H5695 [21JN], E656 [22JN]

——— require Countering Weapons of Mass Destruction Office to treat illicit fentanyl as weapon of mass destruction (H.R. 8030), H5495 [14JN]

Dept. of Justice: permit defendants convicted of certain drug offenses to be eligible for reduced sentences (H.R. 5455), H8625–H8629 [29NO]

——— provide for eligibility of rural community response pilot programs for funding under Comprehensive Opioid Abuse Grant Program (S. 2796), H8745–H8750 [5DE]

——— reauthorize Justice and Mental Health Collaboration Program (S. 3846), H8618–H8622 [29NO]

Dept. of Labor: provide for enforcement of mental health and substance abuse disorder parity requirements, H8235, H8237 [29SE]

Dept. of the Treasury: establish Office of Foreign Assets Control Exchange to advance information sharing and facilitate sanctions administration and enforcement, H6583 [14JY]

Dept. of Veterans Affairs: authorize health care providers to provide recommendations and opinions to veterans regarding participation in State marijuana programs (H.R. 8197), E664 [23JN]

——— ensure certain medical facilities have physical locations for disposal of controlled substances or medications (H.R. 2591), H904 [2FE]

——— furnish Vet Center counseling and mental health services to veterans and Armed Forces members using certain educational benefits, H5852 [23JN]

——— furnish Vet Center counseling and mental health services to veterans and Armed Forces members using certain educational benefits (H.R. 4233), H4951 [13MY]

——— make certain improvements in mental health care (H.R. 6411), H5633 [16JN], H5845–H5853 [23JN], H8186, H8187 [28SE]

Diseases and disorders: global coronavirus vaccine access funding, H4563 [27AP]

——— making supplemental appropriations for coronavirus emergency response and relief, H4158 [5AP]

——— making supplemental appropriations for coronavirus emergency response and relief (H.R. 7007), consideration (H. Res. 973), H1390–H1394 [9MR]

——— prohibit funding for coronavirus vaccine mandate, H971–H973 [4FE]

——— prohibit use of Federal funds to implement or enforce coronavirus vaccine mandates, H4520 [27AP], H8053 [21SE], H8110 [22SE]

——— prohibit vaccination mandates for coronavirus, H343 [2FE]

——— use of budget reconciliation to provide emergency assistance and health care response for individuals, families, and businesses affected by coronavirus pandemic (H.R. 1319), E1302 [15DE]

——— use of certain drugs against coronavirus, H210 [18JA], H250 [19JA], H998 [7FE], H1091 [9FE], H3847 [18MR]

Drug abuse: address drug abuse epidemic by securing southern border, H921, H922 [3FE], H979 [7FE], H1061, H1062–H1067 [8FE], H4059 [31MR], H4461 [26AP], H4583 [28AP], H4848 [11MY], H4869 [12MY], H6925 [21JY], H7080 [26JY], H8746 [5DE]

——— address prescription opioid abuse, H5102 [18MY], H8705 [1DE]

——— designate methamphetamine as emerging threat (S. 854), H1156–H1158 [28FE]

Dye, Christopher J.: tribute (H. Res. 1108), H4875 [12MY]

Economy: use of budget reconciliation to fight inflation, reduce prescription drug and health care costs, address climate change, increase tax fairness, and reduce deficit, H6943 [21JY]

——— use of budget reconciliation to make visionary and transformative investments in health, well-being, and financial security of America’s workers and families, H1298 [3MR]

——— use of budget reconciliation to make visionary and transformative investments in health, well-being, and financial security of America’s workers and families (H.R. 5376), H20 [11JA], H176, H177, H181, H191 [13JA], H249, H251 [19JA], H4570 [27AP]

Eli Lilly and Co.: tribute to shipments of medicine to Ukraine and surrounding areas following Russian invasion, H4812 [11MY]

FDA: clarify reporting requirements for establishments within foreign country engaged in manufacture, preparation, propagation, compounding, or processing of active pharmaceutical ingredients, H827 [2FE]

——— enhance data reporting on clinical trial demographics and provide resources to improve access to clinical trials in underrepresented communities, E594 [8JN]

——— improve regulation of abortion drugs by prohibiting approval of new drugs, preventing labeling changes of existing drugs, and limiting dispensing of drugs remotely, by mail, or telemedicine (H.R. 554), H281 [20JA]

——— reaffirm preemptive authority relative to State laws that inhibit access to or use of any reproductive health product (H. Res. 1434), H9973 [21DE]

——— reaffirm preemptive authority relative to State laws that inhibit access to or use of any reproductive health product (H. Res. 1434), adopt (H. Res. 1529), H9968, H9969 [21DE]

——— revise and extend user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products (H.R. 7667), H5298–H5321 [7JN], E594, E599 [8JN], E629 [15JN]

Federal agencies and departments: review and reassess denial or rescission of security clearances based on marijuana use, H4108, H4109 [1AP]

Federal aid programs: ensure equitable treatment of covered entities and pharmacies participating in 340B drug discount program (H.R. 4390), H5325–H5330 [7JN], H5451 [13JN]

Foundation for the National Institutes of Health: increase funding (S. 1662), H1159 [28FE]

Health: ensure physicians and health care providers advise patients of potential risk of coronavirus vaccine and hold health care providers and pharmaceutical companies liable for any damages, H8110 [22SE]

——— extend certain public health programs (H.R. 9525), unanimous-consent request, H9810 [14DE]

——— increase number of days before which certain controlled substances for maintenance or detoxification treatment must be administered, H5791 [22JN], H5835 [23JN]

——— transfer pharmaceutical civil penalties to NIH Gabriella Miller Kids First Pediatric Research Program Fund (H.R. 623), H7124–H7126 [26JY], H7197, H7223 [27JY]

Health care professionals: require prescribers of controlled substances to complete training on treating patients with opioid and other substance use disorders and incorporate such training in medical school curricula (H.R. 2067), H5737 [22JN]

Horsham, PA: tribute to PMC Pharmacy (business) employees for efforts to combat prescription opioid addiction epidemic while serving needs of chronic pain patients, E700 [7JY]

Immigration: secure border between U.S. and Mexico, H909–H912 [2FE], H8517 [16NO], H8812 [7DE]

Inflation Reduction Act: impact, H7745, H7746 [13SE], H7788, H7795 [14SE], H7846, H7847, H7848, H7863–H7868 [15SE], H7947, H7948, H7950, H7959, H7960 [19SE], H7974, H7981 [20SE], H8123 [28SE], H8228, H8298 [29SE]

Insulin: establish cap on out-of-pocket costs for insulin, H3819 [17MR]

Insurance: establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), H3982, H4003 [30MR], H4022, H4033–H4046, H4053–H4057 [31MR], H4077 [1AP], H4130, H4147, H4148 [4AP], H4199, H4200, H4203 [6AP], H7076 [26JY], E362 [6AP]

——— establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), consideration (H. Res. 1017), H4023–H4033 [31MR]

——— establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), consideration of Senate amendment (H. Res. 1404), H8323–H8330 [30SE]

——— establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), correction in enrollment (S. Con. Res. 45), H8354 [30SE]

——— establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), Senate amendment, H8104 [22SE], H8226 [29SE], H8330–H8350 [30SE]

——— require Pharmacy Benefit Managers to provide greater transparency to group health plan participants, H5780 [22JN]

Lane Change, Inc.: tribute, E162 [18FE]

Marijuana: ban use of ingredients or flavor additives in marijuana-infused products, H4030 [31MR]

——— conduct studies on impact of legalization of marijuana to workplaces and schools and children, H4107, H4108 [1AP]

——— improve medical research by simplifying registration process to conduct research, facilitating access for such research, and allowing private manufacture and distribution for research purposes (H.R. 5657), H4136–H4140 [4AP]

——— make marijuana legal at Federal level, incentivize States to change marijuana laws that disproportionately impact minority communities, and allow retroactive review of marijuana sentences, H4095 [1AP]

——— require child-resistant packaging and warning labels detailing dangers posed to pregnant women and unborn babies for marijuana products, H4030 [31MR]

Medicare: part B premium increase relative to projected cost of Alzheimer’s drug, H238 [19JA]

Medicare/Medicaid: lower prescription drug prices, H4518 [27AP]

Mental health: strengthen parity in mental health and substance use disorder benefits, H1180 [1MR]

National Highway Traffic Safety Administration: conduct study on technologies and methods that law enforcement may use to determine whether driver is impaired by marijuana, H4106, H4107 [1AP], H4147 [4AP]

National objectives: address drug overdose deaths, H6879 [19JY]

——— improve health care services, H6869–H6875 [19JY], H8819–H8821 [7DE], H8863–H8865 [8DE]

National Recovery Month: observance, H7976 [20SE]

News media: urge increased coverage of Russian invasion of Ukraine, illegal border crossings, crime surge, and military training excercises with France, H8584–H8586 [17NO]

Rare Disease Day: designate (H. Res. 948), E185 [28FE]

——— designate (H. Res. 952), E181, E190 [28FE]

Raymond Coalition for Youth: anniversary, E832 [9AU]

Red Ribbon Week: observance, E1049 [14OC]

Republican Party: national agenda, H5720–H5726 [21JN]

Russia: call for provision of evidence of wrongdoing or release of U.S. citizen, Brittney Griner, being detained on drug allegations, H1317 [7MR]

Safety: facilitate responsible, informed dispensing of controlled substances and other prescribed medications, H5778, H5791 [22JN]

Sedalia, MO: tribute to Embassy (organization), E263 [16MR]

States: protect States and individuals in States that have laws which permit use of marijuana, H4095 [1AP]

Stepping Stone, Inc.: funding, H3715 [15MR]

Substance Abuse and Mental Health Services Administration: study certain exemptions for treatment of opioid use disorder through treatment programs during coronavirus emergency and modernize process for obtaining methadone (H.R. 6279), E1211 [2DE]

Supreme Court: decision in National Federation of Independent Business v. Dept. of Labor relative to OSHA rule regarding vaccine mandates for certain businesses, H176 [13JA]

Syria: recognize anniversary of Syrian revolution against Bashar al-Assad, E305 [28MR]

——— require U.S. strategy to disrupt and dismantle Captagon trade and narcotics networks linked to regime of Bashar al-Assad, H9849 [14DE]

——— require U.S. strategy to disrupt and dismantle Captagon trade and narcotics networks linked to regime of Bashar al-Assad (H.R. 6265), H7906–H7908 [19SE], H7984 [20SE]

Utah: tribute to companies for innovation in health care industry, H8128 [28SE], E961 [21SE]

Remarks in Senate

Armed Forces: preserve readiness by limiting separations based on coronavirus vaccination status and continuing pay and benefits for members while religious and health accommodations are pending, S6641 [14NO]

——— prohibit from receiving dishonorable discharge for choosing not to receive coronavirus vaccine, S7209, S7233, S7234 [15DE]

Biden, President: evaluation of administration, S358, S370 [20JA], S631 [10FE], S4597 [14SE], S5118 [28SE]

——— evaluation of administration relative to coronavirus pandemic, S469 [2FE]

——— evaluation of administration relative to immigration, S485 [2FE], S589, S595 [9FE], S658 [14FE], S728 [16FE], S871 [1MR], S1241 [17MR], S1850–S1854 [30MR], S1926, S1929 [4AP], S2136, S2140, S2150 [26AP], S2200, S2206–S2209 [28AP], S2236–S2239 [2MY], S2510 [16MY], S2575–S2577 [18MY], S2650, S2652 [24MY], S2845, S2850–S2855 [8JN], S2906 [13JN], S3103 [23JN], S3196 [11JY], S3248–S3250, S3280–S3284 [13JY], S3297 [14JY], S3325 [18JY], S3524 [20JY], S3709, S3728 [27JY], S4419 [6SE], S4453, S4455, S4464 [7SE], S4547 [13SE], S4814 [19SE], S4889–S4891 [21SE], S4950, S4958 [22SE], S6752, S6755–S6759 [17NO], S6949 [5DE], S7109 [13DE], S7214–S7216 [15DE], S9743, S9744 [21DE]

——— State of the Union Message, S922, S923, S926–S928 [2MR], S969 [3MR]

Centers for Medicare & Medicaid Services: disapprove rule entitled ‘‘Medicare and Medicaid Programs; Omnibus COVID–19 Health Care Staff Vaccination’’ (S.J. Res. 32), S924, S933–S936 [2MR], S963 [3MR]

Children and youth: address shortage of pediatric medication, S7812 [20DE]

Colombia: U.S. policy, S4204 [6AU]

Commission on Combating Synthetic Opioid Trafficking: implement recommendations, S686 [15FE]

Committee on Health, Education, Labor, and Pensions (Senate): accomplishments, S9716–S9718 [21DE]

Congress: accomplishments of 117th Congress, S9 [4JA], S7044 [8DE]

Controlled Substances Act: amend to fix technical error in definitions (S. 4235), S4624 [14SE]

Coronavirus Aid, Relief, and Economic Security (CARES) Act: anniversary, S1284–S1286 [22MR]

Crime: address nationwide increase in violent crime, S2920 [14JN]

——— combat trafficking of illicit fentanyl, S658 [14FE], S3307 [14JY]

——— eliminate disparity in sentencing for crack and powder cocaine offenses (H.R. 1693), S9727–S9729 [21DE]

——— eliminate disparity in sentencing for crack and powder cocaine offenses (H.R. 1693), unanimous-consent request, S9728 [21DE]

——— modify statutory definitions relating to narcotics and drug trafficking (S. 5234), S7103 [12DE]

——— urge development of strategy to counter rise in violent crime (S. Res. 636), S2554, S2564 [18MY]

DEA: codify temporary scheduling order for fentanyl-related substances by adding fentanyl-related substances to schedule I of Controlled Substances Act (S. 3457), S120 [10JA], S272 [18JA]

——— include fentanyl-related substances under schedule I of Controlled Substances Act, designating they have high potential for abuse and no medical use (S. 1006), S5135–S5137 [28SE]

——— include fentanyl-related substances under schedule I of Controlled Substances Act, designating they have high potential for abuse and no medical use (S. 1006), unanimous-consent request, S5136, S5137 [28SE]

Democratic Party: national agenda, S3286 [14JY]

Dept. of Defense: coronavirus vaccine mandate, S6815 [28NO]

Dept. of HHS: allow women greater access to safe and effective oral contraceptive drugs intended for routine use (S. 4638), S3726 [27JY]

——— allow women greater access to safe and effective oral contraceptive drugs intended for routine use (S. 4638), unanimous-consent request, S3726, S3727 [27JY]

——— disapprove rule entitled ‘‘Vaccine and Mask Requirements To Mitigate the Spread of COVID–19 in Head Start Programs’’ (S.J. Res. 39), S2265 [3MY], S2294 [4MY]

——— disapprove rule entitled ‘‘Vaccine and Mask Requirements To Mitigate the Spread of COVID–19 in Head Start Programs’’ (S.J. Res. 39), unanimous-consent agreement, S2259 [3MY]

——— provide for appropriate cost-sharing for insulin products covered under Medicare part D and private health plans (S. 3700), S2345 [5MY]

——— State Opioid Response Grants program funding, S1111, S1112 [10MR]

Dept. of Homeland Security: U.S. Customs and Border Protection chemical screening devices to detect dangerous drugs funding, S4198 [6AU]

Dept. of Justice: reauthorize Justice and Mental Health Collaboration Program (S. 3846), S2480 [12MY], S2669 [24MY], S3149 [23JN], S5122 [28SE], S6952 [5DE]

——— reauthorize Justice and Mental Health Collaboration Program (S. 3846), House amendment, S7185 [14DE]

——— reauthorize residential substance use disorder treatment program (S. 1046), S658 [14FE], S2480 [12MY], S4632 [15SE], S5122 [28SE], S6952 [5DE]

Dept. of State: report on designation of Reynosa/Los Metros of Gulf Cartel, Jalisco New Generation Cartel, Sinaloa Cartel, Cartel Del Noreste of Los Zetas as foreign terrorist organizations (S. 4914), unanimous-consent request, S5125, S5126 [28SE]

Diseases and disorders: making supplemental appropriations for coronavirus emergency response and relief, S961 [3MR], S1006 [7MR], S1024 [8MR], S1070, S1073 [10MR], S1793 [28MR], S1812 [29MR], S1843–S1845, S1849 [30MR], S1876, S1886 [31MR], S1922 [4AP], S1949, S1964, S1965 [5AP], S1992, S2024 [6AP], S2118, S2119 [25AP], S2136 [26AP], S2174 [27AP], S2202 [28AP], S2235 [2MY], S2467 [12MY], S2514 [16MY], S2603 [19MY]

——— modernize process of accelerated approval of drugs for serious or life-threatening diseases or conditions (S. 4446), S3077 [22JN]

——— prepare for, and respond to, existing viruses, emerging new threats, and pandemics (S. 3799), S7060 [8DE]

——— prohibit use of Federal funds to implement or enforce coronavirus vaccine mandates, S775–S777 [17FE], S1106–S1108 [10MR]

District of Columbia: disapprove actions relative to school immunization requirements, S4194 [6AU]

Drug abuse: address drug abuse epidemic by securing southern border, S2175 [27AP], S2530 [17MY], S4951 [22SE]

——— address prescription opioid and heroin abuse, S657 [14FE]

Economy: use of budget reconciliation to fight inflation, reduce prescription drug and health care costs, address climate change, increase tax fairness, and reduce deficit, S3194 [11JY]

——— use of budget reconciliation to fight inflation, reduce prescription drug and health care costs, address climate change, increase tax fairness, and reduce deficit (H.R. 5376), S3729 [27JY], S3749–S3752, S3766–S3768, S3772 [28JY], S3794, S3795, S3797 [1AU], S3837, S3839, S3842, S3853–S3856, S3857, S3858, S3869–S3871 [2AU], S3873, S3874–S3877, S3901, S3994–S3998 [3AU], S4004–S4009, S4015–S4017, S4023, S4026–S4031 [4AU], S4051–S4201, S4210–S4212 [6AU], S4434 [6SE], S4461, S4462 [7SE], S4506 [8SE], S5171 [28SE]

——— use of budget reconciliation to make visionary and transformative investments in health, well-being, and financial security of America’s workers and families (H.R. 5376), S6, S9 [4JA], S470 [2FE], S2141 [26AP], S2348 [5MY]

FDA: allow for alternatives to animal testing for purposes of drug and biological product applications (S. 5002), S5514 [29SE]

——— provide for period of exclusivity for first interchangeable biological products (S. 4303), S2709 [25MY]

——— reform procedures relative to approval of opioid drugs, S685 [15FE]

——— require guidance on extending expiration dates for certain scarce drugs (S. 3493), S191 [12JA]

——— require manufacturers of dietary supplements to list dietary supplements (S. 4090), S2137 [26AP], S4630 [15SE], S7013 [7DE]

——— require prompt reports on marketing status by holders of approved applications for biological products (S. 4302), S2709 [25MY]

——— revise and extend user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, S5171 [28SE]

——— revise and extend user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products (H.R. 7667), S4630 [15SE]

Federal agencies and departments: prohibit from promulgating rules requiring proof of coronavirus vaccination to engage in interstate commerce or travel (S. 2895), S38–S40 [5JA]

——— prohibit from promulgating rules requiring proof of coronavirus vaccination to engage in interstate commerce or travel (S. 2895), unanimous-consent request, S39 [5JA]

FTC: prevent unfair and deceptive acts or practices and dissemination of false information relative to pharmacy benefit management services for prescription drugs (S. 4293), S3021 [21JN], S5133 [28SE]

Garland, Attorney General: assessment of tenure, S1074 [10MR]

Health: address high cost of health care services, prescription drugs, and health insurance coverage, S4553–S4556 [13SE]

——— amend program for local substance use disorder services (S. 3632), S773, S774 [17FE]

——— amend program for local substance use disorder services (S. 3632), unanimous-consent request, S773, S774 [17FE]

——— extend certain public health programs (S. 5244), S7123–S7128, S7150 [13DE], S7153 [14DE]

——— extend certain public health programs (S. 5244), unanimous-consent request, S7124, S7125 [13DE]

——— increase domestic pharmaceutical manufacturing capabilities, S7812 [20DE]

——— urge unvaccinated people to get coronavirus vaccine, S3840 [2AU]

Health care facilities: provide funding to federally-qualified health centers to offer insulin or injectable epinephrine at discounted prices, S4193 [6AU]

Honduras: recognize anniversary of massacre of Ahuas villagers by DEA officers during counternarcotics operations and urge accountability for efforts to misrepresent facts and obstruct resulting investigation, S2445 [11MY]

Immigration: reform, S7013 [7DE], S7806–S7812 [20DE]

——— secure border between U.S. and Mexico, S474–S476 [2FE]

Inflation Reduction Act: impact, S4420, S4423 [6SE], S4452 [7SE], S4953 [22SE], S5038 [27SE]

Insulin: establish cap on out-of-pocket costs for insulin, S1719 [23MR]

Insurance: establish requirements relative to cost-sharing for certain insulin products, S3046 [22JN], S4193 [6AU]

——— establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), S2668, S2669 [24MY], S5147 [28SE], S5509, S5511, S5519, S5520 [29SE]

——— establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), correction in enrollment (S. Con. Res. 45), S5521 [29SE]

——— establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), motion to proceed, S4955 [22SE], S5037, S5041, S5042, S5045 [27SE], S5115–S5117, S5120, S5147 [28SE]

——— establish requirements relative to cost-sharing for certain insulin products (H.R. 6833), unanimous-consent agreement, S5515 [29SE]

International Day Against Drug Abuse and Illicit Trafficking: designate (S. Res. 685), S3028 [21JN]

Law enforcement: prohibit deceptive sale of fentanyl (S. 4984), S5130, S5131 [28SE]

——— prohibit deceptive sale of fentanyl (S. 4984), unanimous-consent request, S5130, S5131 [28SE]

——— decriminalize marijuana at Federal level and provide for taxation and regulation of marijuana products, S620 [10FE]

Medicare: establish cap on costs for covered prescription drugs, S4145–S4147, S4170 [6AU]

——— establish cap on costs for covered prescription drugs (S. 3615), S604–S607 [9FE]

——— establish cap on costs for covered prescription drugs (S. 3615), unanimous-consent request, S604, S607 [9FE]

——— establish improved Medicare for All national health insurance program (S. 4204), S4555 [13SE]

——— exclude certain categories of drugs from price controls for covered prescription drugs, S4181 [6AU]

——— improve access to opioid use disorder treatment services (S. 4618), S3696 [26JY]

——— remedy election revocations relative to administration of coronavirus vaccines (S. 4899), S4871 [20SE]

Medicare/Medicaid: lower prescription drug prices, S5133 [28SE]

——— lower prescription drug prices, improve transparency of pharmaceutical prices and transactions, lower patients’ out-of-pocket costs, and ensure accountability to taxpayers, S429 [1FE], S1039 [8MR], S1883 [31MR], S3189 [11JY], S3321, S3324 [18JY], S3346 [19JY], S3505, S3509, S3520 [20JY], S3582 [21JY], S3620, S3621 [25JY], S3669 [26JY], S3716 [27JY], S4065, S4167 [6AU]

National Fentanyl Awareness Day: designate (S. Res. 624), S2384 [9MY]

National Recovery Month: designate (S. Res. 778), S4878 [20SE]

Older Americans Mental Health Awareness Day: designate (S. Res. 657), S2737 [26MY]

OSHA: disapprove rule relative to mandatory vaccine mandates for certain businesses (S.J. Res. 29), S38 [5JA]

——— provide that rule relative to mandatory vaccine mandates for certain businesses shall have no force or effect (S. 3461), S120 [10JA], S272 [18JA]

Pharmaceuticals: lower prescription drug costs for consumers, S3303 [14JY]

Postal Service: prohibit shipment of abortion-inducing drugs, S1032–S1034 [8MR]

——— prohibit shipment of abortion-inducing drugs, unanimous-consent request, S1033 [8MR]

Republican Party: national agenda, S4942 [22SE]

Senate: prohibit imposition of vaccination, testing, and masking requirements relative to coronavirus for Senate Pages (S. Res. 631), S2473–S2476 [12MY]

——— prohibit imposition of vaccination, testing, and masking requirements relative to coronavirus for Senate Pages (S. Res. 631), unanimous-consent request, S2475 [12MY]

——— tribute to staff working on H.R. 5376, Inflation Reduction Act, S4953 [22SE]

Sports: improve integrity and safety of horseracing by requiring uniform anti-doping and medication control program enforced by independent Horseracing Integrity and Safety Authority, S9765 [21DE]

Temporary Reauthorization and Study of the Emergency Scheduling of Fentanyl Analogues Act: extend (S. 1216), S928–S930 [2MR], S4892 [21SE], S5137 [28SE]

——— extend (S. 1216), unanimous-consent request, S928, S929 [2MR], S5137 [28SE]

Texas: constituent concerns, S4422 [6SE]

Warren, Senator: tribute to staff working on H.R. 5376, Inflation Reduction Act, S4470 [7SE]

Reports

Background On—Marijuana and Impaired Driving: Insurance Information Institute, H4098 [1AP]

Reports filed

Adopt H. Res. 1434, Reaffirm FDA Preemptive Authority Relative to State Laws That Inhibit Access to or Use of Any Reproductive Health Product: Committee on Rules (House) (H. Res. 1529) (H. Rept. 117–660), H9982 [21DE]

Advanced Research Project Agency-Health (ARPA-H) Act: Committee on Energy and Commerce (House) (H.R. 5585) (H. Rept. 117–365), H5485 [13JN]

Campus Prevention and Recovery Services for Students Act: Committee on Education and Labor (House) (H.R. 6493) (H. Rept. 117–384), H5877 [23JN]

Consideration of H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act: Committee on Rules (House) (H. Res. 1017) (H. Rept. 117–285), H4071 [31MR]

Consideration of H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act: Committee on Rules (House) (H. Res. 1191) (H. Rept. 117–381), H5733 [21JN]

Consideration of H.R. 6833, Affordable Insulin Now Act: Committee on Rules (House) (H. Res. 1017) (H. Rept. 117–285), H4071 [31MR]

Consideration of H.R. 7007, Supplemental Appropriations for Coronavirus Emergency Response and Relief: Committee on Rules (House) (H. Res. 973) (H. Rept. 117–269), H1421 [9MR]

Consideration of H.R. 7666, Restoring Hope for Mental Health and Well-Being Act: Committee on Rules (House) (H. Res. 1191) (H. Rept. 117–381), H5733 [21JN]

Consideration of H.R. 7780, Mental Health Matters Act: Committee on Rules (House) (H. Res. 1396) (H. Rept. 117–507), H8219 [28SE]

Consideration of Senate Amendment to H.R. 5376, Inflation Reduction Act: Committee on Rules (House) (H. Res. 1316) (H. Rept. 117–451), H7707 [12AU]

Direct President To Provide Documents With Several Agencies on Recommendations To Reduce Availability of Illicitly Manufactured Fentanyl-Related Substances: Committee on Energy and Commerce (House) (H. Res. 1274) (H. Rept. 117–527), H8313 [29SE]

Direct Sec. of HHS To Provide Documentation to House of Representatives Relative to Negotiation of Prices for Prescription Drugs Under Prescription Drug Program: Committee on Energy and Commerce (House) (H. Res. 1284) (H. Rept. 117–534), H8369 [30SE]

Direct Sec. of Homeland Security To Transmit Documents to House of Representatives Relative to Impact of Illegal Immigration on Federal or Tribal Lands: Committee on the Judiciary (House) (H. Res. 1250) (H. Rept. 117–489), H8111 [22SE]

Direct Sec. of the Interior To Transmit Documents to House of Representatives Relative to Impact of Illegal Immigration on Federal or Tribal Lands: Committee on the Judiciary (House) (H. Res. 1249) (H. Rept. 117–488), H8111 [22SE]

Disaster Assistance Simplification Act: Committee on Homeland Security and Governmental Affairs (Senate) (S. 4599) (S. Rept. 117–163), S5051 [27SE]

Enhancing DHS Drug Seizures Act: Committee on Homeland Security and Governmental Affairs (Senate) (S. 4645) (S. Rept. 117–221), S6962 [5DE]

FDA Safety and Landmark Advancements (FDASLA) Act: Committee on Health, Education, Labor, and Pensions (Senate) (S. 4348), S3269 [13JY]

Fighting Emerging Narcotics Through Additional Nations To Yield Lasting (FENTANYL) Results Act: Committee on Foreign Relations (Senate) (S. 1160), S2939 [14JN]

Interagency Patent Coordination and Improvement Act: Committee on the Judiciary (Senate) (S. 4430), S3860 [2AU]

Justice and Mental Health Collaboration Program Reauthorization: Committee on the Judiciary (Senate) (S. 3846), S2543 [17MY]

Kids First Research Act 2.0: Committee on Energy and Commerce (House) (H.R. 623) (H. Rept. 117–431), H7072 [22JY]

Marijuana Opportunity Reinvestment and Expungement (MORE) Act: Committee on the Judiciary (House) (H.R. 3617) (H. Rept. 117–276), H3862 [24MR]

Mental Health Matters Act: Committee on Education and Labor (House) (H.R. 7780) (H. Rept. 117–484), H8111 [22SE]

Pharmacy Benefit Manager Transparency Act: Committee on Commerce, Science, and Transportation (Senate) (S. 4293), S7199 [14DE]

Prevent Exposure to Narcotics and Toxics (PREVENT) Act: Committee on Homeland Security (House) (H.R. 5274) (H. Rept. 117–375), H5684 [17JN]

Protecting the Border From Unmanned Aircraft Systems Act: Committee on Homeland Security and Governmental Affairs (Senate) (S. 4919) (S. Rept. 117–279), S7310 [19DE]

Request President and Direct Sec. of HHS To Transmit Documents to House of Representatives Relative to Any Coronavirus Vaccine: Committee on Energy and Commerce (House) (H. Res. 1244) (H. Rept. 117–516), H8219 [28SE]

Request President and Direct Sec. of HHS To Transmit Documents to House of Representatives Relative to Ivermectin: Committee on Energy and Commerce (House) (H. Res. 1355) (H. Rept. 117–529), H8313 [29SE]

Restoring Hope for Mental Health and Well-Being Act: Committee on Energy and Commerce (House) (H.R. 7666) (H. Rept. 117–364), H5485 [13JN]

Revise and Extend FDA User-Fee Programs for Prescription Drugs, Medical Devices, Generic Drugs, and Biosimilar Biological Products: Committee on Energy and Commerce (House) (H.R. 7667) (H. Rept. 117–348), H5331 [7JN]

Support the Resiliency of Our Nation’s Great (STRONG) Veterans Act: Committee on Veterans’ Affairs (House) (H.R. 6411) (H. Rept. 117–382), H5821 [22JN]

Terry Technical Correction Act: Committee on the Judiciary (House) (H.R. 5455) (H. Rept. 117–586), H8647 [29NO]

Rulings of the Chair

Economy: use of budget reconciliation to fight inflation, reduce prescription drug and health care costs, address climate change, increase tax fairness, and reduce deficit (H.R. 5376), S4197 [6AU]

Statements

Affordable Insulin Now Act: Adam Brandon, FreedomWorks (organization), H4040 [31MR]

——— National Taxpayers Union, H4040 [31MR]

FDA User-Fee Programs for Prescription Drugs, Medical Devices, Generic Drugs, and Biosimilar Biological Products Goals and Procedures: Xavier Becerra, Sec. of HHS, S5177–S5220 [28SE]

Marijuana and Teens: American Academy of Child and Adolescent Psychiatry, H4098 [1AP]

Marijuana Legalization: American Academy of Child and Adolescent Psychiatry, H4097 [1AP]

Tables

Distributional effects of certain Inflation Reduction Act provisions: Committee on Taxation (Joint), H7655–H7657 [12AU]

Estimated pay-as-you-go effects of H.R. 7667, revise and extend FDA user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, H5330 [7JN]

Texts of

H. Res. 973, consideration of H.R. 7007, supplemental appropriations for coronavirus emergency response and relief, H1390 [9MR]

H. Res. 1017, consideration of H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4023 [31MR]

H. Res. 1017, consideration of H.R. 6833, Affordable Insulin Now Act, H4023 [31MR]

H. Res. 1191, consideration of H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act, H5745 [22JN]

H. Res. 1191, consideration of H.R. 7666, Restoring Hope for Mental Health and Well-Being Act, H5745 [22JN]

H. Res. 1316, consideration of Senate amendment to H.R. 5376, Inflation Reduction Act, H7561 [12AU]

H. Res. 1396, consideration of H.R. 7780, Mental Health Matters Act, H8170 [28SE]

H. Res. 1434, reaffirm FDA preemptive authority relative to State laws that inhibit access to or use of any reproductive health product, H9973 [21DE]

H. Res. 1529, adopt H. Res. 1434, reaffirm FFA preemptive authority relative to State laws that inhibit access to or use of any reproductive health product, H9968 [21DE]

H.R. 623, Kids First Research Act 2.0, H7124 [26JY], H7198, H7223 [27JY]

H.R. 3617, Marijuana Opportunity Reinvestment and Expungement (MORE) Act, H4079–H4087 [1AP]

H.R. 4133, Caribbean Basin Security Initiative appropriations, U.S.-Caribbean security partnership enhancement, and disaster resilience prioritization, H4543 [27AP]

H.R. 5274, Prevent Exposure to Narcotics and Toxics (PREVENT) Act, H5693 [21JN]

H.R. 5376, Inflation Reduction Act, H7577–H7646 [12AU]

H.R. 5455, Terry Technical Correction Act, H8625 [29NO]

H.R. 5585, Advanced Research Project Agency-Health (ARPA-H) Act, H5795–H5798 [22JN]

H.R. 5657, Medical Marijuana Research Act, H4136–H4138 [4AP]

H.R. 6265, Countering Assad’s Proliferation Trafficking and Garnering of Narcotics (CAPTAGON) Act, H7906 [19SE], H7985 [20SE]

H.R. 6411, Support the Resiliency of Our Nation’s Great (STRONG) Veterans Act, H5845–H5851 [23JN]

H.R. 6493, Campus Prevention and Recovery Services for Students Act, H5842 [23JN]

H.R. 6833, Affordable Insulin Now Act, H4033 [31MR]

H.R. 7666, Restoring Hope for Mental Health and Well-Being Act, H5752–H5773 [22JN]

H.R. 7667, revise and extend FDA user-fee programs for prescription drugs, medical devices, generic drugs, and biosimilar biological products, H5298–H5319 [7JN]

H.R. 7780, Mental Health Matters Act, H8242–H8249 [29SE]

H.R. 8454, Medical Marijuana and Cannabidiol Research Expansion Act, H7120–H7122 [26JY]

S. 854, Methamphetamine Response Act, H1156 [28FE]

S. 1662, Supporting the Foundation for the National Institutes of Health and the Reagan-Udall Foundation for the Food and Drug Administration Act, H1159 [28FE]

S. 2796, Rural Opioid Abuse Prevention Act, H8745 [5DE]

S. 3846, Dept. of Justice Justice and Mental Health Collaboration Program reauthorization, S3149 [23JN], H8618 [29NO]

S. 4090, Dietary Supplement Listing Act, S2156 [26AP]

S. 4235, amend Controlled Substances Act to fix technical error in definitions, S4625 [14SE]

S. 4315, Protecting America From Narcotics and Illicit Chemicals (PANIC) Act, S2754 [26MY]

S. 4430, Interagency Patent Coordination and Improvement Act, S3005 [16JN]

S. 4899, Improving Patients With RNHCI Options To Vaccinate Easily (IMPROVE) Act, S4871 [20SE]

S. 5002, FDA Modernization Act 2.0, S5514 [29SE]

S. 5234, Protecting America From Narcotics and Illicit Chemicals (PANIC) Act, S7103 [12DE]

S. Res. 518, address high prevalence of mental health conditions and substance use disorders by making historic financial investments and acknowledging mental health as priority equal to physical health, S789–S791 [17FE]

S. Res. 569, support goals of World Tuberculosis Day, S1870 [30MR]

S. Res. 602, National Adult Hepatitis B Vaccination Awareness Day, S2222 [28AP]

S. Res. 610, express that transnational criminal organizations, including illicit economies, illicit trade, and trade-based money laundering, threaten national interests and national security of U.S. and its allies, S2279 [3MY]

S. Res. 624, National Fentanyl Awareness Day, S2383 [9MY]

S. Res. 631, prohibit imposition of vaccination, testing, and masking requirements relative to coronavirus for Senate Pages, S2495 [12MY]

S. Res. 636, urge development of strategy to counter rise in violent crime, S2522 [16MY]

S. Res. 657, Older Americans Mental Health Awareness Day, S2759 [26MY]

S. Res. 685, International Day Against Drug Abuse and Illicit Trafficking, S3033 [21JN]

S. Res. 704, express concern about economic and security conditions in Mexico and reaffirm interest in mutually beneficial relations based on shared interests on security, economic prosperity, and democratic values, S3274 [13JY]

S. Res. 778, National Recovery Month, S4859 [20SE]

S. Res. 874, express that transnational criminal organizations, including illicit economies, illicit trade, and trade-based money laundering, threaten national interests and national security of U.S. and its allies, S7312 [19DE]

S.J. Res. 32, disapprove Centers for Medicare & Medicaid Services rule entitled ‘‘Medicare and Medicaid Programs; Omnibus COVID–19 Health Care Staff Vaccination’’, S936 [2MR]

S.J. Res. 39, disapprove Dept. of HHS rule entitled ‘‘Vaccine and Mask Requirements To Mitigate the Spread of COVID–19 in Head Start Programs’’, S675 [14FE], S2265 [3MY]